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I. Preface 
An integrated network of hormones regulates the reproductive systems in 
most animal species. Estrogens, one class of hormones, are responsible for the 
development of reproductive organs, and the induction of behavioral and physiological 
processes. 
Estrogens act via intracellular estrogen receptors (ER  and ER ) which are 
members of the nuclear receptor super family of transcription factors. Upon ligand 
binding, ERs enhance the rate of transcriptional initiation by assembling and recruiting 
transcription regulatory complexes to the promoter regions of estrogen responsive 
genes. Estrogens are responsible for estrous cycles, and the development and 
maintenance of female sex characteristics, including behavioral and physiological 
processes. Estrogen exhibits acute and transient actions on its target organs. For 
example, estrogen administration promotes cell proliferation and differentiation in 
adult female reproductive tracts, resulting in weight gains, while estrogen withdrawal 
by ovariectomy induces rapid involution of the uterus and vagina, resulting in return to 
the unstimulated states. These reversible and strict responses to estrogen are important 
in animals to maintain female reproductive organ homeostasis at various physiological 
states, and are required for normal health and reproduction.  
On the other hand, estrogen administration to the neonatal mouse induces 
persistent harmful effects on the reproductive organs; estrogen-independent 
proliferation and cornification in the vaginal epithelium, hyperplastic lesions, 
carcinogenesis and hypospadias in the vagina; uterine hypoplasia, epithelial metaplasia 
5 
and cancers; oviductal cancers; and polyovular follicles and anovulation (Taksugi et al., 
1962; Takasugi, 1976; Forsberg, 1979; Iguchi, 1992; Iguchi et al., 2002). Again, these 
morphological and functional defects in female reproductive organs are induced only 
when the mouse is given estrogen within the early neonatal period (a critical period). 
However, little is known about the relative contribution of the individual ER subtypes 
(ER  or ER ) in the induction of abnormalities. Therefore, I have analyzed the effects 
of neonatal exposure to ER subtype selective ligands and a synthetic estrogen, 
diethylstilbestrol (DES) on female mouse reproductive tracts (Chapter 1). 
Cell proliferation and differentiation of mouse vaginal epithelium are strictly 
regulated by endogenous estrogen during the estrous cycle. There have been many 
reports in regard to the acute and reversible effects of estrogens, however, studies on 
persistent developmental effects to estrogen exposure have never shed light on those 
induction mechanisms (McLachlan, 1980). Miyagawa et al. (2004a, b) reported the 
persistent phosphorylation of ER , erbB receptors and JNK1, and sustained expression 
of EGF-like growth factors, interleukin-1 (IL-1)-related genes and IGF-1 mRNA (Igf1) 
in the neonatally DES-exposed mouse vagina, suggesting an involvement of various 
signaling pathways in the persistent cell proliferation in the mouse vagina induced by 
neonatal DES exposure. These results suggest that neonatal estrogen-exposure induces 
the imprinting in gene expressions, imbalances of cell proliferation and cell death, and 
induction mechanisms of those irreversible phenomena. Therefore, I have performed 
global analyses of the gene expressions in the mouse vagina exposed neonatally to 
DES using microarray technology, and selected candidates of genes and pathways 
possibly related to the persistent vaginal changes induced by neonatal DES exposure 
(Chapters 2 and 3).  
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Moreover, I have analysed the differences in gene expressions, and 
estrogen-dependent signalling pathways between the vagina and uterus (Chapter 4). 
The estrogen-responsive genes in the vagina identified by gene profiling provide an 
important foundation for understanding functional mechanisms of estrogen regulated 
morphogenesis and maintenance of the mouse vagina and uterus. However, no 
comprehensive studies have been conducted on mRNA expressions in these organs in 
mice after estrogen exposure. Therefore, I have analyzed expression of genes in the 
vagina and uterus in ovariectomized mice given a single injection of 17 -estradiol, and 
analysed sequential changes in several estrogen-related signalling pathways.
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II. Chapter 1 
Estrogen Receptor Subtypes Selectively Mediate Female 
Mouse Reproductive Abnormalities Induced by Neonatal 
Exposure to Estrogenic Chemicals 
8 
1. Introduction 
Estrogens tightly regulate cell proliferation and differentiation particularly in 
the oviduct, uterus, vagina and mammary gland of the female reproductive tracts. 
Long-term estrogenic stimulation is a known risk factor for carcinogenesis in humans 
and laboratory animals (Marselos and Tomatis, 1992a,b). Transplacental exposure to 
the synthetic estrogen, diethylstilbestrol (DES), which was routinely prescribed to 
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clear-cell adenocarcinoma in young women (Herbst et al., 1971). It has been 
hypothesized that in utero DES exposure influences the incidence of breast cancer, 
squamous neoplasia of the cervix and vagina, and vaginal clear-cell adenocarcinoma 
later in life (Herbst, 2000; Hatch et al., 2001; Palmer et al., 2002). Therefore, as 
generations of women exposed to DES approach menopause, concerns about possible 
long-term health risks of DES exposure grow. 
Rodent models of DES exposure have been developed to understand the 
mechanistic basis of DES effects on humans. In mice, developmental exposure to 
estrogens within a critical developmental period elicits various permanent alternations 
in the female reproductive tract (Herbst and Bern, 1981). For example, neonatal 
estrogen administration induces persistent epithelial cell proliferation and superficial 
keratinization in the vagina, even after ovariectomy. This results in hyperplastic lesions 
later in life, as well as smooth muscle disorganization and epithelial squamous 
metaplasia in the uterus (Takasugi et al., 1962; McEwen et al., 1977; Forsberg, 1979; 
Iguchi, 1992). 
Miyagawa et al. (2004a,b) previously reported that persistent phosphorylation 
of estrogen receptor  (ER ), erbB receptors and JNK1 and sustained expression of 
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EGF-like growth factors, interleukin-1 (IL-1)-related genes and IGF-1 mRNA (Igf1) 
contributed to persistent activity of these signaling pathways in the neonatally 
DES-exposed vagina. Neonatal treatment of female rats and mice with estrogens and 
estrogenic chemicals induces anovulation and persistent estrus as a consequence of 
insufficient phasic secretion of gonadotropins from the hypothalamic-pituitary axis 
(Takewaki, 1962; Takasugi, 1976; Iguchi, 1992; Kato et al., 2003). 
Estrogens act primarily through the nuclear estrogen receptors, ER  and ER
in mammals. ER  and ER  can be detected in a broad spectrum of tissues. In some 
organs, both ER subtypes are expressed at similar levels, whereas in others, ER  or 
ER  predominate. In addition, both ER subtypes may be present in the same tissue, but 
in different cell types. ER  is mainly expressed in the uterus, prostate (stroma), ovary 
(theca cells), testis (Leydig cells), epididymis, bone, breast, various regions of the 
brain, liver and white adipose tissue. ER  is expressed in colon, prostate (epithelium), 
testis, ovary (granulosa cells), bone marrow, salivary gland, vascular endothelial cells 
and certain regions of the brain (Weihua et al., 2003; Dahlman-Wright et al., 2006). 
ER  knockout ( ERKO) mice were used to study the action of DES. In 
wild-type mice, uterine expression of the genes Hoxa10, Hoxa11 and Wnt7a exhibited 
significant decreases shortly after DES treatment (Ma et al., 1998; Kitajewski and 
Sassoon, 2000), whereas this effect was not observed in the ERKO mice (Couse et al., 
2001). Expression was induced in an estrogen dose-dependent manner for most of the 
genes noted. However, expression of these genes was not altered following estrogen 
treatment in ERKO mice (Watanabe et al., 2002). Adult ERKO mice were 
completely resistant to the chronic effects of neonatal DES exposure such as atrophy, 
decreased weight, smooth muscle disorganization, and squamous metaplasia in the 
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uterine epithelium, proliferative lesions of the oviduct, and persistent vaginal 
keratinization (Couse et al., 2001). Thus, the lack of DES effects on gene expression 
and on tissue differentiation in the ERKO mouse provides unequivocal evidence 
supporting an obligatory role for ER  in mediating the detrimental actions of neonatal 
DES exposure in the murine reproductive tract. Couse et al. (2003) reported that ER , 
but not ER , is indispensable in the negative-feedback effects of estradiol that 
maintain proper LH secretion from the pituitary. ER  appears to be the predominant 
ER in the adult mouse uterus, vagina, oviduct and mammary gland (Couse et al., 2000; 
Korach et al., 2003). Immunohistochemical localization of ER  was demonstrated only 
in differentiating granulosa cells of the ovary where ER  was observed prominently in 
interstitial cells. ER  mRNA was expressed in the female reproductive tract at all ages 
examined with little or no significant levels of ER , except on postnatal day 1 when a 
low level of message appeared (Jefferson et al., 2000). ER  was detectable in the 
uterus of both wild-type and ERKO mice, but only at very low levels (Korach et al., 
2003). The significance of ER  in the induction of polyovular follicles by genistein in 
mice has been reported by Jefferson et al. (2002). Bodo et al. (2006) demonstrated that 
involvement of both ER  and ER  in the sexual differentiation of the anteroventral 
periventricular area in the mouse hypothalamus. 
On the other hand, estrogenic chemicals in the environment have been 
concerned to have potential adverse effects on animals and humans exposed during 
embryonic developmental stage (Damstra et al., 2002). Most of estrogenic chemicals 
bind to ER better than ER  but some chemicals bind to ER  better than ER
(Kuiper et al., 1997). Thus, importance of ER subtypes need to be studied in induction 
of adverse effect by estrogenic chemicals. 
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Recently, ER - and ER -specific ligands have been synthesized and 
characterized using transactivation assays (Harris et al., 2002; Frasor et al., 2003; 
Katzenellenbogen et al., 2003). In this report, I studied the importance of each ER 
subtype in the induction of anovulation through the hypothalamic-pituitary axis with 
persistent estrus, permanent vaginal epithelial cell proliferation, disorganization of 
uterus, and in the induction of polyovular follicles in mice exposed neonatally to 
selective ER ligands or to DES. 
2. Materials and Methods 
2.1. Reagents 
Diethylstilbestrol (DES), 17 -estradiol (E2) and ethinylestradiol (EE2) were 
obtained from Sigma Chemical Co. (St. Louis, MO, USA). Estrogen receptor  (ER ) 
-(4-propyl-[1H]-pyrazole-1,3,5-triyl)trisphenol (propyl 
pyrazole triol, PPT) and ER  specific ligand, 2,3-bis(4-hydroxyphenyl)-propionitrile 
(diarylpropionitrile, DPN) were obtained from Tocris Bioscience (Ellisville, MO, 
USA). Sesame oil and dimethyl sulfoxide (DMSO) were obtained from Kanto 
Chemical (Tokyo, Japan).
2.2. Estrogen Receptor Transactivation Assay 
CHO-K1 cells were seeded in 24-well plates at 5×105 cells/well in phenol-red 
-Aldrich Corp., St. Louis, MO, 
USA) supplemented with 10% charcoal/dextran treated fetal bovine serum (Hyclone, 
South Logan, UT, USA). The cells were transfected overnight with 400 ng of 
pGL3-Basic-4×ERE-tk-luc, 100 ng of pRL-tk-luc (as an internal control to normalize 
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variation in transfection efficiency; contains the Renilla reniformis luciferase gene with 
the herpes simplex virus thymidine kinase promoter; Promega, Madison. WI, USA), 
and 200 ng of pTARGET-mouse ER  (mER ) or mER  using Fugene 6 transfection 
reagent (Roche Diagnostics, Basel, Switzerland) according to the 
manufacturer-recommended protocol. 
After 18 h, doses ranging from 10-12-10-6 M of DES, PPT, DPN, E2 or EE2 were 
administered to the culture media. The cultures were treated with ligands for 24 h, then 
the cells were collected and the luciferase activities of the cells were measured by a 
chemiluminescence assay with Dual-Luciferase Reporter Assay System (Promega). 
Luminescence was measured using a Turner Designs Luminometer TD-20/20 
(Promega). Promoter activity was calculated as firefly (Photinus pyralis)-luciferase 
activity/sea pansy (R. reniformis)-luciferase activity (Katsu et al., 2006). Transfection 
assays were repeated five times. 
2.3. Animals and Treatments 
Female C57BL/6J mice were maintained under 12 h light/12 h dark at 23-25°C 
and fed laboratory chow (CE-2, CLEA, Tokyo, Japan) and tap water ad libitum. All 
procedures and protocols were approved by the Institutional Animal Care and Use 
Committee at the National Institute for Basic Biology, National Institutes of Natural 
Sciences. 
Three female newborn mice were sacrificed and the hypothalamus, ovary, 
uterus and vagina were dissected to measure expression levels of ER  and ER
mRNA. The other female newborn mice were given 5 daily subcutaneous (s.c.) 
injections of 0.025, 0.25 or 2.5 g DES/g body weight (bw) dissolved in sesame oil, 
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0.25, 2.5 or 25 g/g bw PPT or DPN, dissolved in 5.6% DMSO or the vehicle alone 
beginning from day 0 (the day of birth). These mice were ovariectomized at 13 weeks 
and sacrificed at 15 weeks of age. 
Vaginal smears were recorded from 11 weeks of age for 4 weeks. After 
ovariectomy, the dissected ovaries were weighed and fixed in 10% neutral buffered 
formalin. At 15 weeks of age, 6 mice in each experimental group treated with the 
highest concentrations of DES, PPT and DPN, and oil controls were given a single 
injection of 50 g of BrdU/g bw 2 h before sacrifice. The vagina was cut in half 
longitudinally and one horn of each uterus was weighed. Half of the tissue was fixed in 
10% neutral buffered formalin and the other half was frozen in liquid nitrogen for 
analysis of gene expression. 
In addition, 8-19 newborn female mice were given 5 daily injections of 2.5 g 
DES/g bw, 25 g PPT or DPN/g bw or the vehicle alone. These mice were used for 
analysis of polyovular follicles in the ovary at 30 days of age. 
2.4. Hematoxylin and Eosin (HE) Staining and BrdU Immunostaining 
Tissues were embedded in paraffin, sectioned at 8 m, following by standard 
HE staining and analysis of the ovaries, uteri and vaginae. Parts of deparafinized 
sections were incubated in 0.3% H2O2 in methanol for 30 min, then immersed in 2N 
HCl for 20 min in order to denature the genomic DNA. After washing with PBST 
(PBS in 0.5% Tween), the sections were incubated with anti-BrdU antibody 
(Boehringer Mannheim, Mannheim, Germany) diluted 1:20 in PBS containing 1% 
BSA overnight at 4 . 
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The sections were subsequently incubated with 3,3-diaminobenzidine 
tetrahydrochloride containing hydrogen peroxide. BrdU-labeling index was estimated 
by counting the number of BrdU-incorporated cells per h in the basal layer of cells in 
the vaginal epithelium as described previously (Miyagawa et al., 2004a). Polyovular 
follicles containing more than one oocyte in a follicle bigger than 50 m were 
histologically examined and counted as described previously (Iguchi et al., 1986).
2.5. Real-time Quantitative RT-PCR 
Changes in gene expression were confirmed and quantified using the ABI 
Prism 5700 Sequence Detection System (Applied Biosystems, Foster City, USA). 
Total RNA, isolated with RNeasy kit (QIAGEN, Chatsworth, CA, USA) from each 
group, was used in RT-PCR reactions carried out with SuperScript III reverse 
transcriptase (Invitrogen, Carlsbad, CA, USA) and SYBR Green Master Mix (Applied 
follows: 50
for 1 min in 15 l volumes. Relative RNA equivalents for each sample were obtained 
by standardization of ribosomal protein L8 levels. Sequences of gene primer sets are 
given in Table 1. More than three pools of samples per group were run in triplicate to 
determine sample reproducibility, and the average relative RNA equivalents per 
sample were used for further analysis. Error bars represent the standard error, with all 
values represented as fold change compared to the control treatment group normalized 
to an average of 1.0. 
2.6. Statistical Analysis 
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Statistical analyses were performed using one-way or two-way of analysis of 
t-test or Wel t-test followed by 
F-test as appropriate. Differences with P<0.05 were considered significant. 
3. Results 
3.1. Estrogen Receptor Transactivation Assay 
Transactivation assays with mouse ER  revealed that DES, E2 and EE2 showed 
high activity at 10-10 M, whereas the ER -specific ligand, PPT, showed the highest 
transactivation activity at 10-9 M. The estrogenic activity of PPT toward mER  was 10 
times less than DES, E2 and EE2. The ER -specific ligand, DPN, showed no 
significant estrogenic activity to mER , confirming that PPT is an ER  specific ligand 
(Fig. 1A). 
Transactivation of mER  showed the highest activity of DES at 10-10 M, and E2
and EE2 at 10-9 M. DPN showed highest transactivation activity at 10-9 M. As with 
PPT and mER , the estrogenic activity of DPN toward mER  was 10 times less than 
DES, E2 and EE2. PPT showed no significant estrogenic activity toward mER , 
confirming that DPN is an ER  specific ligand (Fig. 1B). Based on these results, the 
doses of PPT and DPN for neonatal mouse were set 10 times higher than those of DES. 
3.2. Vaginal Smear Observation 
Vaginal smears were observed daily from 11 to 15 weeks of age (from 2 weeks 
before ovariectomy until 2 weeks after ovariectomy). Control mice showed regular 
estrous cycles before ovariectomy and diestrous type smears after the ovariectomy. All 
mice given 0.025-2.5 g DES showed constant estrous smears before ovariectomy and 
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4 of 11 mice exposed to 0.025 g, and all of 0.25 and 2.5 g DES exposed mice 
showed constant estrous smears even after ovariectomy. Seven of 11 mice exposed to 
0.025 g DES showed diestrous type smears after ovariectomy. Three of 10, 10 of 11 
and all 16 mice treated neonatally with 0.025, 0.25 and 2.5 g PPT, respectively, 
showed constant estrous smears before ovariectomy. The remaining 7 of 10 and 1 of 
11 mice treated with 0.25 and 2.5 g PPT, respectively, showed estrous cycles before 
ovariectomy. After ovariectomy, 9 of 10 and 9 of 11 mice at the 0.25 and 2.5 g PPT 
showed diestrous smears after ovariectomy. The remaining 1, 2 and 16 mice treated 
with 0.25, 2.5 and 25 g PPT, respectively, showed constant estrous smears even after 
ovariectomy. In neonatally DPN treated mice, 1 of 10 mice at the 0.25 g, and 5 of 16 
at the 25 g showed constant estrous smears. The remaining mice showed regular 
estrous cycles before ovariectomy. After ovariectomy, 2 of 16 mice at the 25 g DPN 
showed constant estrous smears, the rest showed diestrous smears. 
3.3. Ovarian Histology 
Ovaries dissected at 13 weeks of age were examined histologically. All control 
mice showed corpora lutea in the ovary indicating that ovulation had occurred. 
However, all DES-exposed mice lacked corpora lutea in the ovary, demonstrating 
anovulation even at the lowest (0.025 g/g bw) concentration. A significantly higher 
incidence of anovulation was found in mice exposed neonatally to 2.5 and 25 g PPT, 
however, no significant increase in the number of mice showing anovulation was 
induced by 0.25 g of PPT or by any dose of DPN exposure (Table 2, Fig. 2). 
Hyperplastic interstitial cells and lack of corpora lutea were encountered in the ovaries 
of mice exposed neonatally to DES (0.025-2.5 g) and 2.5 and 25 g PPT. In all 
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treatment groups, mice showed regular estrous cycles before ovariecomy had corpora 
lutea, whereas, mice showing constant estrous smears lacked corpora lutea in the 
ovary. 
3.4. Uterine and Vaginal Histology 
The uterine epithelium was composed of a single layer of low columnar cells 
with several uterine glands and circular and longitudinal muscle layers in 
ovariectomized control and 0.25-25 g DPN-exposed mice. Disorganization of stromal 
cells and muscle layers, such as hypoplasia of circular muscle and decrease in density 
of longitudinal muscle, was encountered in mice treated neonatally with 0.025-2.5 g 
DES and 2.5 and 25 g PPT (Table 2, Fig. 2). 
The vaginal epithelium of neonatally oil-injected, 15-week-old ovariectomized 
control and 0.25-25 g DPN-exposed mice was composed of 2-3 layers of cuboidal 
cells. The vaginal epithelium of the age-matched, neonatally 0.25-2.5 g DES- and 25 
g PPT-exposed, ovariectomized mice exhibited stratification and superficial 
keratinization (Table 2, Fig. 3). In the vagina showing ovary-independent epithelial 
stratification, the basal cells in the epithelium showed high proliferative activity 
(18-19%), which was confirmed by BrdU immunostaining. In contrast, the basal cells 
in the vaginal epithelium of ovariectomized controls and DPN-exposed mice showed 
very low incidence (1.7%) of BrdU incorporation (Fig. 3E). 
3.5. Persistent Expression of Growth Factor and IL-1-related Genes 
mRNA expression of Areg (amphiregulin), Ereg (epiregulin), Hbegf 
(heparin-binding epidermal growth factor), Il1r2 (interleukin-1 receptor type II), Il1f5 
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(interleukin-1 family member 5 delta), ESR1 (ER and ESR2 (ER  in the vagina was 
analyzed using real-time quantitative RT-PCR in mice exposed neonatally to 2.5 g 
DES, 25 g PPT and 25 g DPN. The vaginae of mice exposed neonatally to DES and 
PPT showed persistent expression of these genes, but not the vaginae of mice exposed 
to oil or to DPN (Fig. 3F). In addition, the expression of ER  mRNA in the vagina of 
ovariectomized control mice were 1000 times higher than that of ER  (data not shown), 
exhibiting that ER  is the predominant ER in the vagina of ovariectomized adult mice. 
A piece of vagina used for mRNA analysis was also histologically analyzed. I 
confirmed the epithelial stratification in neontally DES- and PPT-exposed mice, but 
not in controls and mice exposed neonatally to DPN. 
3.6. Induction of Polyovular Follicles 
Ovaries dissected at 30 days of age were histologically examined. A high 
incidence of polyovular follicles (PFs) was found in ovaries of mice exposed 
neonatally to 25 g PPT and DPN (3.1% and 4.3%, respectively), although, no 
significant difference was found in the incidence of PFs between mice exposed to PPT 
or DPN. Mice exposed to 2.5 g DES exhibited the highest incidence of PFs in the 
ovary (14%), showing that DES is the most potent inducer of PFs among chemicals 
used in this experiment (Table 3, Fig. 4). 
3.7. Expression of ER  and ER  in Various Tissues of Female Newborn Mice 
The ratio of ER  to ER  mRNA in the hypothalamus, ovary, uterus and vagina 
were analyzed using real-time quantitative RT-PCR in newborn female mice. ER
mRNA expression was higher than that of ER  mRNA in all tissues examined: 
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hypothalamus, 15.0 ± 2.4; ovary, 17.8 ± 4.9; uterus, 33.7 ± 6.1 and vagina, 27.7 ± 5.8 
(the value indicates the ratio of ER  mRNA to ER mRNA, Mean ± S.E.), 
demonstrating that ER  is the predominant ER in these tissues in female newborn 
mice. 
4. Discussion 
I confirmed the selective activation of ER subtypes reviewed previously by 
Katzenellenbogen et al. (2003) using transactivation assays with mouse ER  and ER
(Katsu et al., 2006). In the mER  assay, E2 and DES maximally activated the reporter 
gene at 10-10 M and PPT activated it at 10-9 M. In the mER  transactivation assay, E2, 
DES and DPN maximally activated the reporter gene at 10-10 M. Based on these data, 
the dose of PPT and DPN to be used for in vivo studies was set 10 times higher than 
DES. 
In rodents, administration of aromatizable androgen or estrogen to neonatal 
females induces anovulatory sterility (Barraclough, 1961; Takewaki, 1962; Gorski, 
1963; Takasugi, 1976; Iguchi et al., 1988; Aihara and Hayashi, 1989; Kincl, 1990; 
Iguchi, 1992), whereas castration of neonatal male rats evokes the capacity for sexual 
cyclicity and lordosis behavior that is characteristic of the female rat. These treatments 
are considered to masculinize or defeminize the brain (Goy and McEwen, 1980; Iguchi 
et al., 1988). ER  and ER  expression has been demonstrated in the mouse brain 
(Mitra et al., 2003). ER  knockout ( ERKO) mice are sterile, ERKO mice are fertile, 
but the average number of offspring is less than that of wild type mice (Couse and 
Korach, 1999; Couse et al., 2003). This demonstrates the critical importance of ER  in 
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the normal development of the hypothalamic-pituitary-ovarian (HPG) axis. Couse et al. 
(2003) further demonstrated that ER  is indispensable to the negative-feedback effects 
of estradiol that maintain proper LH secretion from the pituitary.  
Plastic component, bispheno-A (BPA) and phytoestrogen, genistein, bind to 
ER  about 7 times better than they do ER  (Kuiper et al., 1997). Neonatal exposure to 
BPA induced anovulatory sterility in female rats (Kato et al., 2003). Also, neonatal 
exposure to BPA, or to genistein affected sexual differentiation of the anteroventral 
periventricular nucleus of the hypothalamus (Patisaul et al., 2006). I, therefore, studied 
effects of neonatal exposure to ER selective ligands on the hypothalamus. In the 
present study, vaginal smears of mice exposed neonatally to 0.025-2.5 g DES and to 
2.5 and 25 g of the ER  specific ligand, PPT, showed constant estrus. However, mice 
exposed to the ER  specific ligand, DPN, showed cyclic smear patterns. Mice showing 
constant estrous smear patterns that were exposed neonatally to DES and PPT had no 
corpus luteum in the ovary, indicating anovulatory sterility. These results clearly 
suggest that ER , but not ER , mediates most of the estrogenic effects of chemicals on 
the HPG axis during critical developmental stages. 
In newborn mice, ER  is localized in the uterine stromal cells, but not in the 
epithelial cells whereas it is expressed in both epithelial and stromal cells in the vagina 
(Sato et al., 1992). The present study confirmed that ER  is the predominant form of 
ER in the uterus and vagina as reported previously (Jefferson et al., 2000; Couse and 
Korach, 2004). The present study demonstrated that the ratio of ER /ER  is bigger in 
the adult vagina than the newborn vagina.  
In tissue recombination experiments, ER -negative uterine epithelium (derived 
from the ERKO mouse uterus) recombined with ER -positive stroma, showed 
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proliferation following estrogen stimulation, whereas wild type epithelium recombined 
with ER -negative uterine stroma did not proliferate (Cooke et al., 1997; Buchanan et 
al., 1998, 1999). These reports suggested that epithelial cell proliferation could be 
mediated indirectly by ER  in the stroma. In cell culture conditions, estrogen did not 
stimulate vaginal or uterine epithelial cell proliferation (Iguchi et al., 1983; Iguchi, 
1985), however, estrogen stimulated DNA synthesis in human endometrial epithelial 
cells co-cultured with stromal cells in a transfilter system (Pierro et al., 2001). Estrogen 
stimulated vaginal and uterine stromal cell proliferation in culture (Inada et al., 2006). 
Thus, ER  activity in stromal cells is essential for estrogen-mediated epithelial cell 
proliferation in mouse reproductive tracts. Perinatal treatment with estrogens (e.g., E2, 
DES, EE2), aromatizable and non-aromatizable androgens, or BPA induce 
ovary-independent persistent proliferation of vaginal epithelium with superficial 
keratinization (Takasugi, 1976; Iguchi, 1992; Suzuki et al., 2002; Inada et al., 2006). 
No such changes in the vagina were induced in the neonatally DES-exposed ERKO 
mice (Couse and Korach, 2004), indicating the essential role of ER  in the induction 
of ovary-independent vaginal changes induced by estrogens. Here I showed that 
persistent vaginal epithelial cell proliferation with the superficial keratinization was 
induced by neonatal treatment with 0.25-2.5 g DES or 25 g PPT, but not DPN. 
Neonatal treatment with 0.025-2.5 g DES or 2.5-25 g PPT induced disorganization 
of circular muscle in the uterus; however, DPN did not induce this abnormality. These 
results also indicate that ER  action is essential for induction of uterine muscular 
disorganization and ovary-independent persistent vaginal epithelial cell proliferation 
caused by estrogens during the critical developmental stage. 
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In the persistently proliferating vaginal epithelial cells in mice exposed 
neonatally to DES, it has been reported that phosphorylation of ER  and erbB2 
receptor, and persistent expression of genes related to epidermal growth factor, such as 
amphiregulin (Areg), epiregulin (Ereg), heparin-binding EGF (Hbegf), interleukin-1 
(IL-1) receptor type II (Il1r2), IL-1 family member 5 (delta) (Il1f5), tumor necrosis 
factor-  and insulin-like growth factor-I (Miyagawa et al., 2004a,b). The present 
results show that the persistent expression of Areg, Ereg, Hbegf, Il1r2 and Il1f5 in 
vagina of mice treated neonatally with DES and PPT, but not DPN. These results 
indicate that ER  action is also essential for the induction of persistent molecular 
changes in the vagina. 
Perinatal treatment with estrogens such as E2, DES, EE2 and genistein induces 
polyovular follicles (PFs) in the ovary (Iguchi, 1985; Iguchi and Takasugi, 1986; 
Iguchi et al., 1986; Jefferson et al., 2002; Kirigaya et al., 2006; Kipp et al., 2007). 
Neonatal treatment with a large dose of BPA also induced PFs in mice (Suzuki et al., 
2002). The critical period for induction of PFs is within 3 days after birth in mice 
(Iguchi et al., 2002). ER  is localized in interstitial and thecal cells, whereas ER  is 
localized in granulosa cells in the ovary (Jefferson et al., 2002). ER  is the 
predominant form in the ovary (Jefferson et al., 2002; Couse and Korach, 2004). ER
is critical in granulosa cell differentiation and the ovulatory response to gonadotropins 
(Couse et al., 2005). Neonatal exposure of genistein induced PFs in wild-type and 
ERKO female mice, but not in ERKO females, and the induction of PFs in the 
ovary is dependent on the presence of functional ER  within the ovary (Jefferson et al., 
2002). Our results show that neonatal treatment with PPT or DPN equally induce PFs 
in ovaries; therefore, both ER  and ER  are involved in the induction of PFs. 
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However, expression of ER  mRNA was higher than that of ER  mRNA in the ovary 
of newborn mice. E2, progesterone and genistein disrupt nest breakdown and 
primordial follicle formation, which may result in the PFs in mouse ovary (Chen et al., 
2007). Kipp et al. (2007) showed that PFs induced by neonatal DES or E2 exposure 
were accompanied by decreased levels of activin -subunit mRNA and protein. This 
resulted in loss of phosphorylation of Smad 2 protein, a marker of activin-dependent 
signaling, in the estrogen-treated ovaries. Therefore, both ER subtypes may be 
involved in these molecular and histological changes in the newborn mouse ovary. 
Estrogenic chemicals in the environment potentially have adverse effects on 
animals including humans when exposed during development (Damstra et al., 2002). 
Most of estrogenic chemicals bind to ER  better than ER , but some chemicals such 
as genistein, coumestrol, BPA etc. bind to ER  better than ER  (Kuiper et al., 1997). 
Ratio of ER /ER  is different among tissues as demonstrated in the present study. The 
present results suggest that chemicals having affinity to ER  as well as chemicals 
having affinity to ER  can induce adverse effects when exposed during critical 
sensitive periods, which differ among tissues (Iguchi et al., 2002). ER specific ligands 
can be used to understand the involvement of ER subtypes in various 
estrogen-mediated diseases such as mammary cancer and endometriosis.  
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Fig. 1. Estrogenic activities of ER selective ligands, natural and synthetic estrogens for 
mouse ER  (A) and mouse ER  (B) in reporter gene assays. DES (diethylstilbestrol), 
PPT (propyl pyrazole triol); ER  specific lignad, DPN (diarylpropionitrile); ER
specific ligand, E2 (17 -estradiol) and EE2 (ethinylestradiol). *P<0.05 vs controls 
(two-way ANOVA). 
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Fig. 2. Histology of ovaries in 13-week-old mice exposed neonatally to oil (A), 2.5 g 
DES (B), 25 g PPT (C) and 25 g DPN (D) for the first 5 days. Note corpora lutea 
(cl) in oil control mouse and DPN-treated mouse. Histology of uteri of 15-week-old, 
ovariectomized mice exposed neonatally to oil (E), 2.5 g DES (F), 25 g PPT (G) and 
25 g DPN (H) for the first 5 days. Note disorganization of muscle layers in DES- and 
PPT-treated mice. cm: circular muscle, lm: longitudinal muscle. Bar: 100 m. 
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Fig. 3. Histology of vaginae of 15-week-old, ovariectomized mice exposed neonatally 
to oil (A), 2.5 g DES (B), 25 g PPT (C) and 25 g DPN (D) for the first 5 days. 
Note ovary-independent persistent proliferation of vaginal epithelium in DES- and 
PPT-treated mice. Bar: 50 m. Incidence of BrdU-incorporation (%) in basal cells of 
vaginal epithelium of mice exposed neonatally to oil, 2.5 g DES, 25 g PPT and 25 
g DPN (E). *P<0.05 vs controls (one-way ANOVA). Persistent expression of mRNAs 
of growth factors, interleukin-1-related genes and estrogen receptors in mouse vagina 
exposed neonatally to oil, 2.5 g DES, 25 g PPT or 25 g DPN for the first 5 days (F). 
Expression of Areg (amphiregulin), Ereg (epiregulin), Hbegf (heparin-binding 
epidermal growth factor), Il1r2 (interleukin-1 receptor type II), Il1f5 (IL-1 family, 
member 5), Esr1 (estrogen receptor ER ) and Esr2 (ER ) in vagina show higher 
levels in DES- and PPT-treated mice than those of controls and DPN-treated mice. The 
expression of each mRNA in vagina of the oil-treated control mice was regarded as the 
basal level (1.0). ** t- t-test followed by 
F-test). 
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Fig. 4. Histology of ovaries in 30-day-old mice exposed neonatally to oil (A), 2.5 g 
DES (B), 25 g PPT (C) and 25 g DPN (D) for the first 5 days. Note polyovular 





III. Chapter 2 
WNT Family Genes and Their Modulation in the 
Ovary-independent and Persistent Vaginal Epithelial Cell 
Proliferation and Keratinization Induced by Neonatal 
Diethylstilbestrol Exposure in Mice 
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1. Introduction 
Estrogen-induced cell proliferation and differentiation in female reproductive 
organs such as oviduct, uterus and vagina are long being studied by several group of 
researchers (Takasugi et al., 1962; Dunn and Green, 1963; Takasugi and Bern, 1964; 
Forsberg, 1969; Herbst et al., 1971; McLachlan et al., 1980; Newbold and McLachlan, 
1982; Newbold et al, 1985; Iguchi et al., 1986, Iguchi, 1992). Diverse biological 
effects of estrogens are primarily mediated via the activation of nuclear estrogen 
receptors, ER  and ER , which are ligand-inducible transcription factors (Tsai and 
ia ER  or 
ER  after estrogen exposure in mice has been silenced by an ER antagonist, ICI 
182,780 (Miyagawa et al., 2004a,b). 
Vaginal epithelium is an intriguing model for analyzing the estrogen action in 
mice. It undergoes characteristic changes from a non-keratinized to a fully keratinized 
epithelium depending on the levels of the endogenous estrogen, estradiol (E2), during 
the estrous cycle (Miller et al., 1998).  
Estrogen exposure, during a critical period in the early development in mice, 
induces persistent, ovary-independent proliferation and keratinization in the vaginal 
epithelium at adulthood (Takasugi et al., 1962; Takasugi and Bern, 1964). In humans, 
trans-placental exposure to a synthetic estrogen, diethylstilbestrol (DES), which was 
routinely prescribed to pregnant women for prevention of miscarriages from the 1940s 
to 1970s in the USA and European countries, resulted in vaginal clear-cell 
adenocarcinoma in young women (Herbst et al., 1971). Although perinatal estrogenic 
chemical exposure induces various abnormalities, i.e., polyovular follicles, oviductal 
tumors, uterine epithelial metaplasia, persistent vaginal stratification and keratinization, 
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vaginal adenosis, and cervico-vaginal carcinomas (Takasugi et al., 1962; Dunn and 
Green, 1963; Takasugi and Bern, 1964; Forsberg, 1969; Newbold and McLachlan, 
1982; Newbold et al, 1985; Iguchi et al., 1986; Iguchi, 1992; Suzuki et al., 2002), the 
critical period of estrogen action during mouse development varies from organ to 
organ (Iguchi et al., 2002). DES exposure during critical developmental period results 
in alterations of the response to estrogens in mouse vagina, leading to a set of 
subsequent abnormalities. Among them, vaginal epithelial proliferation persists even 
after ovariectomy in mice exposed to sufficient doses of DES during the early neonatal 
period (Takasugi et al., 1962; Takasugi and Bern, 1964).  
Wnt genes are the vertebrate homologs of wingless, the Drosophila segment 
polarity gene comprised of 16 members. They are a large group of highly conserved 
secreted glycoproteins, and play crucial roles in embryonic developmental processes 
(Cadigan and Nusse, 1997; Wodarz and Nusse, 1998; Smalley and Dale, 1999), 
tumorigenesis (Tsukamoto et al., 1988; Smalley and Dale, 1999; Lustig and Behrens, 
2003) and reproduction (Parr and McMahon, 1998; Vanino et al., 1999) mostly via 
Frizzled (Fz) receptor (Dale, 1998). Fzs constitute a large family of seven 
transmembrane G protein-coupled receptors and possess an extracellular cysteine-rich 
domain (CRD) for Wnt/binding (Wang et al., 1996; Liu et al., 1999). Among several 
Wnt-mediated intracellular signaling pathways (Willert and Nusse, 1998; Huelsken 
and Birchmeier, 2001; van Noort and Clevers, 2002), the canonical Wnt -catenin 
pathway has been well studied.  
The Wnt singling is highly responsive to variable hormone concentration and 
location (Wever-Hall et al., 1994). It is well known that Wnt singling plays roles in 
epithelial-mesenchymal interactions and cellular organization during embryonic and 
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postembryonic development, involving in cell proliferation and differentiation, cell 
fate specification and cell-to-cell communication (Cadigan and Nusse, 1997; Wodarz 
and Nusse, 1998; Smalley and Dale, 1999). Wnt signaling also plays a key role in 
murine female reproductive tract development (Miller et al., 1998; Daikoku et al., 
2004), and has been suggested as a target for potential endocrine disruptors (Sassoon, 
1999). Miller et al. (1998) reported that three Wnt family genes, Wnt4, Wnt5a and 
Wnt7a, were expressed in the uterus and cervix in specific epithelial-mesenchymal 
interactions during postnatal development and in the adult. However, the expression of 
Wnt genes in vagina has not yet been elucidated. 
Previously, Miyagawa et al. (2004a,b) examined the global expression of 
mRNA, focusing on factors involved in cell signaling in the vagina of mice exposed 
neonatally to DES showing persistent hyperplasia and the superficial keratinization. In 
the present study, I report that neonatal exposure of DES and ER  specific ligand 
induced persistent up-regulation of Wnt4 and persistent down-regulation of Wnt11 in 
mouse vagina. In addition, to clarify the role of Wnt4 in vaginal histological 
modulation by estrogen, I used Wnt4 hetero (Wnt4+/-) mice, since Wnt4-/- mice exhibit 
fetal lethality (Stark et al., 1994; Vainio et al., 1999). Wnt4 expression was correlated 
to epithelial keratinization, in mouse vagina exposed neonatally to DES.
2. Materials and Methods 
2.1. Reagents 
Diethylstilbestrol (DES) was obtained from Sigma Chemical Co. (St. Louis, 
MO, USA). Estrogen receptor  (ER ) specific ligand, 
-(4-propyl-[1H]-pyrazole-1,3,5-triyl)trisphenol (propyl pyrazole triol, PPT), 
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ER  specific ligand, 2,3-bis(4-hydroxyphenyl)-propionitrile (diarylpropionitrile, DPN) 
and estrogen receptor antagonist, ICI 182,780, were obtained from Tocris Bioscience 
(Ellisville, MO, USA). Sesame oil and dimethyl sulfoxide (DMSO) were obtained 
from Kanto Chemical (Tokyo, Japan). 
2.2. Animals and treatments 
C57BL/6J mice and 129+Ter/Sv mice were purchased from CLEA Japan (Tokyo, 
Japan). Wnt4 mutant mice (129+Ter/Sv strain) were from Jackson Laboratory (Bar 
Harber, ME, USA) through Prof. K.-I. Morohashi. They were maintained under 12 h 
light/12 h dark at 23-25°C and fed laboratory chow (CE-2, CLEA) and tap water ad 
libitum. All procedures and protocols were approved by the Institutional Animal Care 
and Use Committee at the National Institute for Basic Biology, National Institutes of 
Natural Sciences. 
C57BL female newborn mice were given 5 daily subcutaneous (s.c.) injections 
of 0.025 (n=6), 0.25 (n=6) or 2.5 g (n=6) DES/g body weight (bw) dissolved in 
sesame oil or the oil vehicle alone (n=6) beginning from day 0 (the day of birth). 
Ovariectomy was performed in all mice exposed neonatally to DES, since the aim of 
the present study was to understand the underlying molecular mechanisms of ovary 
(estrogen)-independent persistent vaginal changes. These mice ovariectomized at 8 
weeks and sacrificed at 10 weeks of age were used for DNA microarray analysis, 
reverse transcriptase polymerase chain reaction (RT-PCR), histology and 
immunohistochemistry. In addition, mice exposed to 2.5 g DES/g bw neonatally and 
ovariectomized as adults (n=8) were given 5 daily intraperitoneal injections of 5 g ICI 
182,780/g bw or oil vehicle alone beginning from day 65 and killed 24 h after the last 
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injection. Tissues were used for real-time quantitative RT-PCR and histological 
examination for counting number of vaginal epithelial cell layers. 
Newborn female C57BL mice were given 5 daily s.c. injections of 2.5 g 
DES/g bw (n=4), 25 g/g bw PPT (n=4) or DPN (n=4) dissolved in 5.6% DMSO or 
the vehicle alone (n=4) beginning from day 0. These mice ovariectomized at 13 weeks 
were sacrificed at 15 weeks of age, and used for real-time quantitative RT-PCR and 
histology. 
Wnt4+/+ and Wnt4+/- newborn mice were given 5 daily s.c. injections of 2.5 g 
DES/g bw dissolved in oil (n= 10 or 4, respectively) or the oil vehicle alone (n=5 each). 
These mice ovariectomized at 8 weeks were sacrificed at 10 weeks of age, and 
analyzed Wnt4 mRNA expression and histology. 
2.3. DNA microarray analysis 
Total RNA from vaginae exposed neonatally to 0.025, 0.25 or 2.5 g DES/g 
bw or oil vehicle alone were extracted using TRIZOL (Invitrogen, Carlsbad, CA, 
USA) and purified using an RNeasy mini kit (QIAGEN, Chatsworth, CA, USA). 
Quality and quantity of total RNA were confirmed by the Agilent 2100 Bioanalyzer 
(Agilent, Palo Alto, CA, USA). cRNA probes were prepared from the purified RNA 
using an Affymetrix cRNA probe kit (Affymetrix, Santa Clara, CA USA) according to 
Affymetrix for use on their expression array. The amplified cRNA was hybridized to 
high-density oligonucleotide arrays (Mouse U74A; Affymetrix) containing 
approximately 12500 genes, and the scanned data were analyzed with GeneChip 
software (Affymetrix) and processed as described previously (Watanabe et al., 2004). 
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To confirm the estrogen-related changes in gene expression revealed by DNA 
microarray analysis, I independently repeated the same experiment twice. The 
expression data were analyzed with GeneSpring software (Agilent) as described 
previously (Watanabe et al., 2004). 
For the clustering analysis, genes expressed more than 2-fold or less than a half 
by neonatal DES treatment to controls were selected, and similarities between 
experiments and expression levels were measured by standard correlation using the 
GeneSpring program as described previously (Watanabe et al., 2002, 2003, 2004). 
2.4. RT-PCR and real-time quantitative RT-PCR 
Total RNA, isolated with RNeasy kit (QIAGEN, Chatsworth, CA, USA) from 
each group of vaginae, was used in RT-PCR or real-time quantitative RT-PCR 
reactions carried out with SuperScript III reverse transcriptase (Invitrogen). RT-PCR 
was carried out using AmpliTaq Gold (TAKARA, Ohtsu, Japan). Sequences of gene 
primer sets are given in Table 4. PCR conditions were 
in 25 l volumes. 
Changes in gene expression were confirmed and quantified using ABI Prism 
5700 Sequence Detection System (Applied Biosystems, Foster City, CA, USA) and 
l volumes. Relative RNA 
equivalents for each sample were obtained by standardization of ribosomal protein L8 
levels. Sequences of gene primer sets are given in Table 4. More than three pools of 
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samples per group were run in 3-7 groups to determine sample reproducibility, and the 
average relative RNA equivalents per sample were used for further analysis. Error bars 
represent the standard error, with all values represented as fold change compared to the 
control group normalized to an average of 1.0. 
2.5. HE staining and immunohistochemistry 
Tissues were fixed in neutral buffered 10% formalin, embedded in paraffin and 
sectioned at 8 m. Some sections were stained with standard hematoxylin and eosin. 
Other sections deparafinized were incubated with 0.3% H2O2 in methanol for 15 min to 
eliminate endogenous peroxidase. After washing with PBS, the sections were 
incubated anti-Wnt4 antibody (R&D Systems, Inc., Minneapolis, MN, USA) at 1:200 
dilution in PBS containing 1% BSA (Sigma) overnight at 4 . The sections were 
visualized with LSABTM 2 kit, Universal (Dako, Carpinteria, CA, USA) according to 
the manufacturer-supplied protocol. For negative controls, normal goat 
immunoglobulin fraction (Dako) was used at the same dilution.
2.6. Statistical analysis 
Statistical analyses were performed using one-way analysis of variance 
t- t-test followed by F-test as appropriate. 
Differences with P<0.05 were considered significant. 
3. Results 
3.1. DNA microarray analysis 
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Microarray analyses was performed to get an idea about the expression profiles 
of different Wnt genes, especially, Wnt4, Wnt5a, Wnt5b, Wnt7b and Wnt11 mRNA in 
the mouse vagina (Table 5). Surprisingly, only Wnt4 and Wnt7b showed higher (3-6 
fold) to moderate (1.97-2.42 fold) spikes in the neonatally DES-exposed mouse vagina 
than controls. On the other hand, Wnt11 showed a decrease (0.21-0.29 fold) after DES 
treatment. However, other Wnt genes remained unaffected in vaginal epithelia after 
neonatal DES treatment. To verify the results of microarray analysis, I examined the 
expression of Wnt4 and Wnt11 mRNA using RT-PCR. Similar to microarray analysis, 
Wnt4 or Wnt11 expression was up- or down-regulated, respectively, in the vaginal 
epithelium of DES-exposed mice than controls (data not shown). Interestingly, 
mRNAs of all Frizzled family (Fz 1 to 10) were detected in the mouse vagina 
regardless of the neonatal DES exposure (data not shown). Henceforth, further studies 
were conducted with Wnt4 and Wnt11 only.  
3.2. Estrogen responsive changes of Wnt genes in mouse vagina 
Neonatal DES exposure induced vaginal epithelial stratification with superficial 
keratinization which was not abolished by ovariectomy (Fig. 5A, D). By contrast, 
neonatally oil-treated control mice had atrophied vaginal epithelium after ovariectomy 
(Fig. 5C, D). Expressions of Wnt4 mRNA was high and Wnt11 mRNA was low in the 
vagina of ovariectomized mice exposed neonatally to DES, however, the expression 
patterns in these genes in the vagina of ovariectomized mice exposed neonatally to oil 
vehicle alone were reversed (Fig. 5E, F). To investigate the transcriptional regulation 
of Wnt4 and Wnt11 mRNA by exogenous estrogen, I administrated ER antagonist, ICI 
182,780, to neonatally 2.5 g DES-exposed, ovariectomized mice, showing vaginal 
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epithelial stratification and superficial keratinization. Wnt4 expression in the neonatally 
DES-exposed mouse vagina, which treated with ICI 182,780, was significantly 
decreased, but Wnt11 expression was not changed by anti-estrogen exposure. 
Surprisingly, the number of vaginal epithelial cell layers in ICI 182,780-treated mice 
exposed neonataly to DES, were significantly decreased (Fig. 5B, E, F). This 
suggested that the DES-responsive changes in Wnt expressions and estrogen 
responsive epithelial cell proliferation are actually correlated. 
To ascertain the role of Wnt genes in vaginal epithelial cell proliferation, I 
performed immunohistochemistry (IHC) of Wnt4. Ten-week-old ovariectomized mice 
exposed neonatally to 2.5 g DES or oil vehicle alone, were used for IHC with 
anti-Wnt4 antibody (Fig. 6). Wnt4 staining was observed in the basal and middle 
layers of epithelial cells in vagina of mice exposed neonatally to DES (Fig. 6A), but no 
Wnt4 staining was observed in oil-treated control mouse vagina (Fig. 6C). This 
suggests that Wnt4 might be associated with epithelial cell proliferation and further 
keratinization. I also found that Wnt4 was expressed in the vagina showing epithelial 
cell proliferation, while Wnt11 was restricted to the atrophic vagina having 2-3 
epithelial cell layers. 
To pinpoint the role of specific estrogen receptor on such transcriptional 
modulation of Wnt genes and related cell proliferation, I analyzed both Wnt4 and 
Wnt11 mRNA expression and epithelial cell proliferation and keratinization in vagina 
of 15-week-old ovariectomized mice treated neonatally with 25 g DPN, 25 g PPT or 
2.5 g DES. The vaginal epithelium of these ovariectomized mice exhibited epithelial 
cell proliferation, stratification and superficial keratinization (Fig. 7A-D). Wnt4
expression was found to increase after neonatal DES or PPT treatment (Fig. 7E). A 
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simultaneous decrease in Wnt11 expression was also observed in DES- or PPT-treated 
vagina (Fig. 7F). However, DPN treatment neither changed the Wnt4 and Wnt11
expression nor epithelial cell proliferation. Vaginal epithelia of ovariectomized mice 
treated neonatally with oil (Fig. 7A) or 25 g DPN (Fig. 7D) were composed of 2-3 
layers of cuboidal cells only. This highlights only Wnt4, but not Wnt11, is responsible 
for the persistent vaginal epithelial cell proliferation and persistent activation of ER
(Miyagawa et al., 2004a,b). 
To clarify the role of Wnt4 in vaginal histological modulation by estrogen, I 
used Wnt4 hetero (Wnt4+/-) mice, since Wnt4-/- mice exhibit fetal lethality (Stark et al., 
1994; Vainio et al., 1999). I thought that Wnt4 expression levels in the vagina of wild 
type (Wnt4+/+) mice were higher than Wnt4+/- mice. All Wnt4+/+ and Wnt4+/- mice 
treated neonatally with oil, vaginal epithelia were composed of 2-3 layers of cuboidal 
cells (Table 6). While, all neonatally DES-exposed Wnt4+/+ and Wnt4+/- mice exhibited 
vaginal epithelial stratification or stratification with superficial keratinization (Table 6). 
Wnt4 expression levels and histology in vaginae between Wnt4+/+ and Wnt4+/- mice 
were not different. Wnt4 was highly expressed in neonatally DES-exposed mice both 
in Wnt4+/+ and Wnt4+/- mice (Fig. 8A), showing epithelial stratification with superficial 
keratinization (Fig. 8B, C). The vagina of Wnt4+/+ and Wnt4+/- mice exposed 
neontatally to DES having only epithelial stratification show no up-regulation of Wnt4 




In the present study, I intended to clarify the mechanism of ovary-independent 
proliferation of vaginal epithelial cells. First, I analyzed global gene expression 
patterns in the DES-exposed mouse vagina. Both microarray analysis and RT-PCR 
showed differential interplay of Wnt family genes after DES-exposure. Especially, 
neonatal DES and ER  specific ligand exposure induced persistent up-regulation of 
Wnt4 or persistent down-regulation of Wnt11 in mouse vagina. In addition, I also 
found that DES induces ER-mediated epithelial stratification and keratinization 
regulated by Wnt4. 
During embryonic development, members of the Wnt gene family express in a 
diverse fashion. Pavlova et al. (1994) have previously noted that murine Wnt gene 
family, Wnt5a, were abundant in the adult female reproductive tract, but become 
relatively scarce during gestation. In addition to Wnt4, Wnt5a and Wnt7a are also 
detected at high levels in the murine female reproductive tract and had a specific 
mesenchymal-epithelial expression pattern (Miller et al., 1998). However, these 
expressions fluctuate along with estrus cycle progression (Miller et al., 1998). In 
present study, I confirmed the expressions of several Wnt family genes, i.e., Wnt4, 
Wnt5a, Wnt5b, Wnt7b and Wnt11 mRNA in the neonatally DES-exposed or oil control 
mouse vagina using DNA microarray analysis. Although I recorded an elevated 
expression for Wnt4 and Wnt7b, and reduced expression of Wnt11, but Wnt5a and 
Wnt5b remain unchanged. Therefore, I decided to focus on Wnt4 and Wnt11 genes in 
the vagina exposed neonatally to DES. 
Wnt4 is known to be involved in multiple development processes, such as the 
formation of kidney, adrenal gland, female reproductive tracts and various cancers 
(Connony and Schnitt, 1993; Stark et al., 1994; Kispert et al., 1998; Brisken et al., 
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2000; Smalley and Dale et al., 2001; Jeays-Ward et al., 2004; Yu et al., 2006). Wnt11
is a non-canonical Wnt family, regulates ureteric branching (Majumdar et al., 2003), 
and cardiogenesis (Pandur et al., 2002). In the line of microarray results, our tissue 
distribution data also suggested similar respective up- and down-regulation of Wnt4
and Wnt11 expression after neonatal DES exposure. The reduction in Wnt11 after DES 
exposure suggests their repressive role in Wnt pathway (Maye et al., 2004). However, 
the expression of Fz genes, receptors of Wnt4 (Lyons et al., 2004), did not change in 
DES-treated vagina, suggested that Wnt4 might have other function unrelated to Fzs. 
Cellular localization of protein gives an idea about the potential target. Miller et 
al. (1998) reported the localization of Wnt4 mRNA in mouse reproductive tract using 
in situ hybridization, however, no information of the localization of Wnt4 protein in 
the vagina. In the present study, Wnt4 protein was localized in the vaginal epithelium 
of mice exposed neonatally to DES, especially in the basal epithelial cell layer. Saitoh 
et al. (1998) reported that Wnt4 protein plays a role in epidermal-dermal (presumably 
keratinocyte-fibroblast) interactions in the skin. Wnt4 is possibly participating in cell 
proliferation or keratinization in the mouse vaginal epithelium.  
In this regard, our earlier reports suggest that DES-induced persistent 
proliferation in vagina is actually mediated through ER  (Nakamura et al., 2008). 
Moreover, in wild-type mice, uterine expression of Hoxa10, Hoxa11 and Wnt7a genes 
exhibited significant decrease shortly after DES treatment (Ma et al., 1998; Kitajewski 
and Sassoon, 2000; Couse et al., 2001), whereas this effect was not observed in the 
ERKO mice (Couse et al., 2001). This supports the idea about the obligatory role for 
ER  in DES-induced alteration of mouse reproductive tract. Interestingly, in the 
present study, only PPT, but not DPN, induced a similar magnitude of Wnt4 and Wnt11
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expression as in DES-exposed vagina. This suggests that the changes in Wnt4 and 
Wnt11 profile are ER  responsive. But anti-estrogen mediated reduction of Wnt4, but 
not Wnt11, confirms that Wnt4 action is regulated by ER  and Wnt11 might be 
regulated by androgen receptor as in prostate cancer (Zhu et al., 2004). 
Finally, I used Wnt4+/- mutant mice to study the function of Wnt4 in the 
estrogen-induced vaginal epithelial stratification and keratinization, since Wnt4-/-
mouse show fetal lethality (Vainio et al., 1999; Majumdar et al., 2003). Wnt4+/- mice 
exposed neonatally to DES showed vaginal epithelial stratification with the superficial 
keratinization similar to wild-type mouse exposed neonatally to DES. However, Wnt4
was highly expressed in vagina showing epithelial stratification with the superficial 
keratinization. Keratins have long and extensively been used as immunohistochemical 
markers in diagnostic tumor pathology (Moll et al., 2008; Karantza, 2011). 
Interestingly, Wnt11 was significantly down-regulated in the vagina of mice showing 
ovary-independent persistent epithelial proliferation. This confirms that Wnt4 and 
Wnt11 might show the opposite behavior in the mouse vagina. Wnt4 expression was 
correlated to the keratinization of vaginal epithelium. 
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Fig. 5. Administration of anti-estrogen, ICI 182,780, reduced proliferation of vaginal 
epithelial cells in 10-week-old, ovariectomized mice exposed neonatally to 2.5 g DES. 
Vaginal histology of ovariectomized mice exposed neonatally to DES (NeoDES) treated 
with oil vehicle [NeoDES + Oil (A)] or 5 g ICI 182,780/g bw [NeoDES + 5 g/g bw 
ICI 182,780 (B)] and ovariectomized mice exposed neonatally to oil vehicle alone and 
oil before sacrifice [NeoOil + Oil (C)] before sacrifice. Sections were stained with 
hematoxylin and eosin. Number of vaginal epithelial cell layers was significantly 
decreased in mice treated with ICI 182,780 (D). Expression profiles of Wnt gene 
mRNA in vagina of NeoDES mice treated with oil or ICI 182,780. Wnt4 mRNA 
expression was significantly decreased in mice treated with ICI 182,780 (E), but Wnt11




Fig. 6. Immunohistochemistry by Wnt4 antibody. Vaginae of 10-week-old, 
ovariectomized mice exposed neonatally to 2.5 g DES (A, B) or oil vehicle alone (C, 
D). Wnt4 localized in epithelium cells of DES-exposed vagina, especially, in basal layer 
and middle layers (A). Control mouse vagina was not expressed Wnt4 protein (C). No 
immunostaining was noted when sections were incubated with preimmune serum 
instead of primary antibody (B, D). Bar: 50 m. The boundary between epithelium and 
stroma is indicated by a dotted line. 
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Fig. 7. Histology of vaginae of 15-week-old, ovariectomized mice exposed neonatally 
to oil (A), 2.5 g DES (B), 25 g PPT (C) and 25 g DPN (D) for the first 5 days. Note 
ovary-independent persistent proliferation of vaginal epithelium in DES- and 
PPT-treated mice. Neonatal 2.5 g DES or 25 g PPT treatment for the first 5 days 
induced persistent up-regulation of Wnt4 mRNA (E), and persistent down-regulation of 
Wnt11 mRNA (F) in mouse vagina. The expression of each mRNA in vagina of the 
oil-treated controls was regarded as the basal level (1.0). Bar: 50 m. *P<0.05 vs 
controls, **P<0.01 vs controls (one-way ANOVA). 
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Fig. 8. Vaginae of 10-week-old, ovariectomized Wnt4+/+ or Wnt4+/- mice exposed 
neonatally to 2.5 g DES or oil vehicle alone. Neonatal exposure to 2.5 g DES 
induced persistent up-regulation of Wnt4 mRNA in vaginae of both Wnt4+/+ and Wnt4+/- 
mice (A). Wnt4 mRNA expression was significantly correlated to the vaginal epithelial 
cell proliferation with the superficial keratinization but not for the proliferation only in 
Wnt4+/+ (B) and Wnt4+/- mice (C). Since only one Wnt4+/- mouse showed epithelial 
stratification only, therefore, statistical analysis could not be done. The number of mice 
showing vaginal epithelial atrophy, stratification only and stratification with 
keratinization are correlated to the Table 6. *P<0.05 vs controls, ***P<0.001 vs 
t- t-test followed by F-test).  
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Table 4. Sequences of gene primer sets for real-time quantitative RT-PCR 
Gene - a Product size (bp) Gene accession no. 
Wnt4 F: CATCGAGGAGTGCCAATACCA 70 NM_009523 
R: GACAGGGAGGGAGTCCAGTGT 
Wnt11 F: ATGTGCGGACAACCTCAGCTA 100 NM_009519 
R: CGCATCAGTTTATTGGCTTGG  
aF, forward; R, reverse. 
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Table 5. Microarray date of Wnt genes in vaginas of adult mice (10 week-ages) exposed neonatally to DES  
Gene accession no. Name 
Fold change 
Prove set ID 
0.025 0.25 2.5 
NM_021279 wingless-related MMTV integration site 1 NC NC NC 1425377_at 
NM_023653 wingless-related MMTV integration site 2 NC NC NC 1449425_at 
NM_009520 wingless-related MMTV integration site 2b NC NC NC 1421465_at 
NM_009521 wingless-related MMTV integration site 3 NC NC NC 1450763_x_at 
NM_009522 wingless-related MMTV integration site 3A NC NC NC 1422093_at 
NM_009523 wingless-related MMTV integration site 4 4.15 5.95 3.23 1450782_at 
NM_009524 wingless-related MMTV integration site 5A 0.82 0.91 1.33 1436791_at 
NM_009524 wingless-related MMTV integration site 5A 1.29 1.13 1.03 1448818_at 
NM_009525 wingless-related MMTV integration site 5B NC NC NC 1422602_a_at 
NM_009525 wingless-related MMTV integration site 5B NC NC 0.80 1439373_x_at 
NM_009526 wingless-related MMTV integration site 6 NC NC NC 1419708_at 
NM_009527 wingless-related MMTV integration site 7A NC NC NC 1423367_at 
NM_001163634 wingless-related MMTV integration site 7B NC 2.42 1.97 1420891_at 
NM_001163634 wingless-related MMTV integration site 7B NC NC NC 1420892_at 
NM_009290 wingless-related MMTV integration site 8A NC NC NC 1422228_at 
NM_011720 wingless-related MMTV integration site 8b NC NC NC 1421439_at 
NM_011720 wingless-related MMTV integration site 8b NC NC NC 1421440_at 
NM_139298 wingless-type MMTV integration site 9A NC NC NC 1425889_at 
NM_011719 wingless-type MMTV integration site 9B NC NC NC 1451711_at 
NM_009518 wingless-related MMTV integration site 10a NC NC NC 1460657_at 
NM_011718 wingless-related MMTV integration site 10b NC NC NC 1426091_a_at 
NM_009519 wingless-related MMTV integration site 11 0.21 0.21 0.29 1450772_at 
NM_053116 wingless-related MMTV integration site 16 NC NC NC 1422941_at 
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Table 6. Effect of neonatal treatment of DES on vaginae of Wnt4+/- and Wnt4+/+ mice ovariectomized  




No. of mice showing vaginal epitherial 
atrophy stratification stratification with keratinization 
Oil Wnt4 +/+ 5 5 0 0 
Wnt4 +/- 5 5 0 0 
2.5 g/g bw DES Wnt4 +/+ 10 0 3 7 
Wnt4 +/- 4 0 1 3 
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IV. Chapter 3 
p21 and Notch Signalings in the Persistently Altered Vagina 
Induced by Neonatal Diethylstilbestrol Exposure in Mice 
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1. Introduction 
Long-term estrogenic stimulation is a known risk factor for carcinogenesis in 
laboratory animals and humans (Marselos and Tomatis, 1992a,b). In humans, 
transplacental exposure to a synthetic estrogen, diethylstilbestrol (DES), induced 
vaginal clear-cell adenocarcinoma in young women (Herbst et al., 1971). In mice, 
developmental exposure to estrogens within a critical developmental period elicits 
various permanent alternations in female reproductive tracts (Takasugi and Bern, 1964; 
Forsberg, 1969; Newbold and McLachlan, 1982; Newbold et al., 1985; el-Deiry et al., 
1993; Miyagawa et al., 2004a,b; Nakamura et al., 2008, 2012). For example, neonatal 
estrogen administration induces persistent vaginal epithelial cell proliferation and 
keratinization even after ovariectomy, resulting in hyperplastic lesions and vaginal 
cancers later in life (Takasugi et al., 1962; McLanhlan et al., 1980; Gartel and Tyner, 
1999).  
Previously, Miyagawa et al. (2004a,b) and Suzuki et al. (2006) characterized the 
mRNAs expression patterns in the neonatal mouse vagina exposed to DES at different 
ages and the persistently altered vagina by neonatal DES exposure using DNA 
microarray and real-time quantitative RT-PCR. In the vagina of mice exposed 
neonatally to DES, expressions of various genes were modulated, and interleukin-I 
(IL-I) and insulin-like growth factor-I (IGF-I) signalings were activated without 
estrogen stimulation (Miyagawa et al., 2004b). In particular, IGF-I receptor (IGF-IR) 
and its downstream factor, Akt, were phosphorylated, which may lead to persistent cell 
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proliferation and differentiation in the mouse vagina (Miyagawa et al., 2004a,b). In the 
vagina of mice exposed to DES at different ages showed genes related to keratinocyte 
differentiation and cell cycle-related genes, such as Gadd45a, 14-3-3 sigma, Sprr2f
(small proline-rich protein 2f), Klf4 (Kruppel-like factor 4) and p21, were induced by 
DES (Suzuki et al., 2006).  
p21 (also called WAF1, CAP20, Cip1 and Sdi1) (Forsberg, 1969; Xiong et al., 
1993; Noda et al., 1994; Harper et al., 1995), founding member of the Cip/Kip family of 
CKIs including p27 (Polyak et al., 1994; Toyoshima and Hunter, 1994) and p57 
(Toyoshima et al., 1994; Lee et al., 1995) can bind and inhibit a broad range of 
cyclin/Cdk complexes, with a preference for those containing Cdk2 (Xiong et al., 1993; 
Hartman et al., 2004). p21 plays an essential role in growth arrest after DNA damage 
(Dunn et al., 1963; Deng et al., 1995; Devgan et al., 2005), and its over-expression leads 
to G1 and G2 (Niculescu et al., 1998) or S-phase (Ogryzko et al., 1997) arrest. Moreover, 
the anti-oncogenic effect of Notch family gene, which is one of the fundamental 
signaling pathway that regulate metazoan development and adult tissue homeostasis, 
appears to be mediated by p21 and by repression of Shh and Wnt signalings (Dulic et al., 
1994; Thelu et al., 2002; Nicolas et al., 2003). Wnt signaling suppressed by Notch1 
activation in keratinocytes, showing that Notch1 activation down-regulates this pathway 
by suppressing Wnt-4 expression (Dulic et al., 1994). p21 mediates this negative 
regulation; Notch1 activation increased p21 protein levels, which subsequently 
associates with E2F1 transcription factors at the Wnt4 promoter, down-regulating Wnt4
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expression (Dulic et al., 1994). On the other hand, p21 is often responsible for 
stress-induced p53-dpendent and p53-independent cell cycle arrest, which permits cells 
to pause and to repair damage and then to continue cell division (Harper et al., 1993), 
and p21 expression has been shown to be regulated largely at the transcriptional level 
by both p53-dependent and -independent mechanisms (Harper et al., 1993). 
I, therefore, focused on the p21, p53 and Notch signaling in order to understand the 
molecular mechanisms underlying the persistently altered vagina by neonatal DES 
exposure in mice. 
2. Materials and Methods 
2.1. Reagents
Diethylstilbestrol (DES) was obtained from Sigma Chemical Co. (St. Louis, MO, 
USA). Estrogen receptor  (ER ) specific ligand, 
-(4-propyl-[1H]-pyrazole-1,3,5-triyl)trisphenol (propyl pyrazole triol, PPT) and 
ER  specific ligand, 2,3-bis(4-hydroxyphenyl)-propionitrile (diarylpropionitrile, DPN), 
were obtained from Tocris Bioscience (Ellisville, MO, USA). Sesame oil and dimethyl 
sulfoxide (DMSO) were obtained from Kanto Chemical (Tokyo, Japan).  
2.2. Animals and treatments
C57BL/6J mice purchased from CLEA Japan (Tokyo, Japan) were maintained 
under 12 h light/12 h dark at 23-25°C and fed laboratory chow (CE-2, CLEA) and tap 
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water ad libitum. All procedures and protocols were approved by the Institutional 
Animal Care and Use Committee at the National Institute for Basic Biology, National 
Institutes of Natural Sciences. 
The middle part of the vagina, Müllerian duct origin, was used for current study. 
Female newborn mice were given 5 daily subcutaneous (s.c.) injections of 2.5 g DES/g 
body weight (bw) (n=6) dissolved in sesame oil or the oil vehicle alone (n=6) beginning 
from day 0 (the day of birth). These mice were ovariectomized at 8 weeks and 
sacrificed at 10 weeks of age (n=6, in each experimental group). These mice were used 
for DNA microarray analysis. 
Newborn females were given 5 daily s.c. injections of 2.5 g DES/g bw (n=4), 
25 g/g bw PPT (n=4) or DPN (n=4) dissolved in 5.6% DMSO or the vehicle alone 
(n=4) beginning from day 0. These mice, ovariectomized at 13 weeks, were sacrificed at 
15 weeks of age and vaginae were used for real-time quantitative RT-PCR and 
immunohistochemistry. Since I have already demonstrated that there is no age 
difference in histology and gene expression at least between 2-4 months in neonatally 
DES exposed ovariectomized mice (Miyagawa et al., 2004a,b; Nakamura et al., 2008, 
2012). I used preserved mouse vaginae treated abovementioned chemicals to save 
animal use. 
2.3. DNA microarray analysis
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Total RNA from vaginae exposed neonatally to 2.5 g DES/g bw or oil vehicle 
alone were extracted using TRIZOL (Invitrogen, Carsbad, CA) and purified using an 
RNeasy mini kit (Qiagen, Chatsworth, CA, USA). Quality and quantity of total RNA 
were confirmed by the Agilent 2100 Bioanalyzer (Agilent, Palo Alto, CA, USA). cRNA 
probes were prepared from the purified RNA using an Affymetrix cRNA probe kit 
(Affimetrix, Santa Clara, CA, USA) according to 
preparations met the recommended criteria of Affymetrix were applied for their 
expression array. The amplified cRNA was hybridized to high-density oligonucleotide 
arrays (Mouse U74A; Affymetrix) and the scanned data were analyzed with GeneChip 
software (Affymetrix) and processed as described previously (Watanabe et al., 2004). 
To confirm the estrogen-related changes in gene expression revealed by DNA 
microarray analysis, I independently repeated the same experiment twice. The 
expression data were analyzed with GeneSpring software (Agilent) as described 
previously (Watanabe et al., 2002, 2003, 2004). 
2.4. Real-time quantitative RT-PCR
Total RNA, isolated with RNeasy kit (Qiagen) from vaginae of each group, was 
used for real-time quantitative RT-PCR reactions carried out with SuperScript III 
reverse transcriptase (Invitrogen). 
Changes in gene expression were confirmed and quantified using the ABI Prism 
5700 Sequence Detection System (Applied Biosystems, Foster City, CA, USA) and 
58 
SY
instructions. PCR conditions were as follows: 50
l. Relative RNA equivalents for 
each sample were obtained by standardization of ribosomal protein L8 levels. 
Sequences of gene primer sets are given in Table 7. More than three pools of samples 
per group were run in triplicate to determine sample reproducibility, and the average 
relative RNA equivalents per sample were used for further analysis.  
2.5. Immunohistochemistry
Tissues were fixed in 10% neutral buffered formalin, embedded in paraffin and 
sectioned at 4 m. Deparafinized sections were incubated with 0.3% H2O2 in methanol 
for 15 min to eliminate endogenous peroxidase. After washing with PBS, the sections 
were stained with LSABTM 2 kit, Universal (Dako, Carpinteria, CA, USA) according to 
the manufacturer-supplied protocol. Anti-p21 monoclonal antibody was obtained from 
Santa Cruz, Inc. (Minneapolis, MN, USA). The sections were incubated at 1:50 dilution 
in PBS containing 1% BSA (Sigma) overnight at 4 . For negative controls, murine 
IgG2b (Dako) was used at the same dilution. 
2.6. Statistical analysis
t- t-test 
followed by F-test as appropriate. Differences with P<0.05 were considered significant. 
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3. Result 
3.1. DNA microarray analysis
11,219 of 22,689 in Genechip probes were detected in vaginae of 10-week-old 
control or 2.5 g DES-exposed mice, ovariectomized at 8 weeks of age. 423 probes 
were up-regulated and 351 probes were down-regulated as compared to the controls in 
the vagina exposed neonatally to DES (data not shown). I further analyzed genes related 
to cell cycle. 26 genes (31 probes) were up-regulated (Table 8) and 8 genes (10 probes) 
were down-regulated (Table 9) in DES-exposed vagina as compared to oil controls. 
3.2. p21 and p53 mRNA expression
Since the expression of p21 was specifically up-regulated in the cell 
cycle-related genes compared to controls, I analyzed p21 mRNA expression in vaginae 
of 15-week-old ovariectomized mice exposed neonatally to 25 g DPN, 25 g PPT and 
2.5 g DES. Because we previously showed the persistent proliferation and 
keratinization of epithelial cells in the vagina exposed neonatally to DES and PPT 
(Nakamura et al., 2008, 2012). p21 expression was very low in vagina of controls and 
neonatally 25 g DPN-exposed ovariectomized mice. In contrast, p21 was up-regulated 
in the vagina of mice exposed neonatally to 2.5 g DES and 25 g PPT (Fig. 9). p53 
mRNA, unlike p21 mRNA, was unaltered in the DES-, PPT- and DPN-exposed vagina 
(Fig. 9). 
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3.3. p21 protein localization
I performed immunohistochemistry to investigate the localization of p21. 
Fifteen-week-old, ovariectomized mice given neonatal exposure to 2.5 g DES or the 
oil vehicle alone were stained with p21 antibody (Fig. 10A, C) or murine IgG2b as a 
negative control (Fig. 10B, D). p21 was localized in the basal layer of vaginal epithelial 
cells in mice exposed neonatally to DES (Fig. 10A), but no p21 staining was observed 
in the oil-treated controls (Fig. 10C) showing correlation of p21 expression and 
proliferation of the vaginal epithelial cells. 
3.4. The expression of Notch signal pathway related genes in the vagina of mice 
exposed neonatally to DES, PPT or DPN
I analyzed the expression of genes related to Notch signal pathway, however, all 
Notch receptors mRNA ( Notch 1, Notch 2, Notch 3 and Notch 4) (Fig. 11A) and Notch 
ligands mRNA (Dll 1, Dll 4, Jagged 1 and Jagged 2) (Fig. 11B) were unaltered in the 
DES-exposed vagina. Whereas, the expression of Notch target genes, Hes1, Hey1 and 
Heyl, was significantly decreased in the vagina exposed neonatally to DES or PPT 
compared to the control and neonatally DPN-treated mice (Fig. 11C). 
4. Discussion 
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Estrogens tightly regulate cell proliferation and differentiation in the female 
reproductive tracts (Takasugi et al., 1962; Iguchi, 1992). However, perinatal exposure 
of estrogens including synthetic estrogen, DES and other estrogenic chemicals, induces 
persistent anovulation caused by alteration of hypothalamo-pituitary-gonadal axis, 
polyovular follicles, uterine abnormalities and persistent vaginal changes in mice 
(Takasugi et al., 1962; Takasugi and Bern, 1964; Herbst et al., 1971; Forsberg, 1979; 
Newbold and McLachlan, 1982; Newbold et al., 1985; Iguchi et al., 1986; Iguchi, 1992; 
el-Deiry et al., 1993; Suzuki et al., 2002, 2006). Especially, transplacental exposure to 
DES, which was routinely prescribed to pregnant women for preventing miscarriages in 
- -cell adenocarcinoma in young women (Herbst et 
al., 1971). It has been hypothesized that in utero DES exposure influences the incidence 
of breast cancer, squamous neoplasia of the cervix and vagina, and vaginal clear-cell 
adenocarcinoma later in life (Herbst et al., 1971; Herbst, 2000; Hatch et al., 2001; 
Palmer et al., 2002).  
DNA microarray has been successfully used to analyze estrogen-responsive 
genes in the mouse vagina, and genes possibly related to persistent vaginal epithelial 
cell proliferation induced by neonatal DES-exposure (Miyagawa et al., 2004b; 
Watanabe et al., 2004; Suzuki et al., 2006; Nakamura et al., 2012a). In the present study, 
I found up-regulation of cell cycle-related genes in the persistently proliferating vaginal 
epithelial cells of neonatally DES-exposed mice. Especially, p21 mRNA showed 
persistent up-regulation in the vagina with irreversible proliferation, and p21 was 
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localized in the basal layer of vaginal epithelial cells. However, the expression of p53
mRNA did not changed in the DES- and PPT-exposed mouse vagina. A number of 
previous studies suggested that p21 was regulated by p53-independent mechanisms. 
Notably, many of these studies suggested that serum and other growth factors, e.g. 
epidermal growth factor (EGF), might be involved in the up-regulation of p21 in 
various cell types (Michieli et al., 1994; Macleod et al., 1995). Moreover, Akt 
phosphorylated by PI3K leads to the stabilization of p21 and enhanced tumor cell 
survival (Li et al., 2002). Previously, Miyagawa et al. (2004a,b) found the 
phosphorylation of Akt, and persistent expression of some growth factors in the 
neonatally DES-exposed vagina. In the present study, p21 might be regulated by 
p53-independent mechanisms, and the expression of p21 might be involved in the 
persistent epithelial proliferation in mouse vagina exposed neonatally to DES or PPT. 
Notch family genes are evolutionarily conserved and participate in a variety of 
cellular processes; for example, cell fate decision (including proliferation, 
differentiation and apoptosis), cardiovascular development, endocrine development and 
cancer (Lathia et al., 2008; Kopan et al., 2009; Tien et al., 2009; Radtke et al., 2010). 
Anti-oncogenic effect of Notch1 in murine skin appears to be mediated by p21 
induction and by repression of Wnt signaling (Dulic et al., 1994). In the present study, 
mRNA expression of Notch receptors (Notch 1, Notch 2, Notch 3 and Notch 4) and 
Notch ligands (Dll 1, Dll 4, Jagged 1 and Jagged 2) were not changed in the vagina 
exposed neonatally to DES and PPT, suggesting that these signalings are not regulated 
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by p21-dependent mechanisms, and not be involved in the persistent vaginal changes 
induced by neonatal DES or PPT exposure. Further studies are needed to clarify this 
phenomenon.  
On the other hand, the expression of other Notch target genes, i.e. Hes1 (Sasai et 
al., 1992), Hey1 (Maier and Gessler, 2000) and Heyl, was permanently down-regulated 
in the neonatally DES- or PPT-exposed vagina. Hes/Hey gene dosage is essential not 
only for generation of appropriate numbers of hair cells and supporting cells by 
controlling cell proliferation, but also for the hearing ability by regulating the cell 
migration, cell alignment and polarity (Tateya et al., 2011). Moreover, over-expression 
of HEY-1 inhibits migration and proliferation, whereas, inhibition of HEY-1 expression 
disrupts the processes of alignment and tube formation and re-establishment of the 
mature vessel phenotype (Brugarolas et al., 1995). Irreversible epithelial proliferation in 
the vagina exposed neonatally to DES might be affected with down-regulation of Hes1, 
Hey1 and Heyl. Ström et al. (2000) and Hatch et al (2001) have previously shown that 
the expression of HES-1 is down-regulated by 17 -estradiol (E2), and forced expression 
of HES-1 inhibits an E2-mediated proliferation of breast cancer cells. Moreover, Müller 
et al. (2009) have revealed that novel negative ERE associating with the HES-1 
promoter and recruiting nuclear receptor co-regulators to the ERE in response to E2, 
then docking in the HES-1 promoter region. In the present study, down-regulation of 
Hes family genes in the vagina exposed neonatally to DES or PPT, might be responsible, 
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at least in part, for the irreversible epithelial proliferation caused by permanent 
activation of ER  (Miyagawa et al., 2004a,b). 
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Fig. 9. Expression of p21 (A) and p53 (B) mRNA in vaginae of 15-week-old 
ovariectomized mice exposed neonatally to 2.5 g DES (n=4), 25 g PPT (n=4), 25 g 
DPN (n=4) or the oil vehicle alone (n=4) for the first 5 days. The expression of each 
mRNA in vagina of the oil-treated controls was regarded as the basal level (1.0).  
t- t-test followed by F-test). 
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Fig. 10. Immunohistochemistry of p21. Vaginae of 15-week-old ovariectomized mice 
exposed neonatally to 2.5 g DES (A, B) or the oil vehicle alone (C, D). p21 was 
immunostained in the neonatally DES-exposed vagina (A) and the age-matched control 
mouse vagina (C). As negative controls, sections were incubated with pre-immune 
serum instead of primary antibody (B, D). Staining of blood vessels in the stroma is 
no-specific reaction. The boundary between the epithelium and stroma is indicated by a 
dotted line. Bar: 50 m. 
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Fig. 11. mRNA expressions of Notch-related genes in vaginae of 15-week-old 
ovariectomized mice exposed neonatally to 2.5 g DES (n=4), 25 g PPT (n=4), 25 g 
DPN (n=4) or oil vehicle alone (n=4) for the first 5 days. (A) Notch receptor genes 
(Notch 1, Notch 2, Notch 3 and Notch 4), (B) Notch ligand genes (Dll 1, Dll 4, Jagged 1
and Jagged 2), and (C) HES/HEY family genes known as Notch target genes (Hes 1, 
Hey 1 and Hey l). The expression of each mRNA in vagina of the oil-treated control 
mice was regarded as the basal level (1.0). *P<0.05 vs t-test or 
t-test followed by F-test).  
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Table 7. Sequences of gene primer sets for real-time quantitative RT-PCR   
Gene - a Product size (bp) Gene accession no. 
p21 F: GTACTTCCTCTGCCCTGCTG 70 NM_001111099 
R: AGAGTGCAAGACAGCGACAA 
p53 F: AAAGGATGCCCATGCTACAG 92 NM_011640 
R: TATGGCGGGAAGTAGACTGG 
Notch 1 F: ACCCACTCTGTCTCCCACAC 123 NM_008714  
R: GCTTCCTTGCTACCACAAGC 
Notch 2 F: GAGTGTCTGAAGGGCTACGC 66 NM_010928  
R: GGGGTCTGAATGACACTCGT 
Notch 3 F: CTCTGTGGTGATGCTGGAGA 109 NM_008716  
R:AATCAAGTCGCTCCACTGCT 
Notch 4 F: CAGAACGTGGATCCCCTCAAGTTGC 70 NM_010929  
R: AGGCAGAGAGAGGGCAAGGAGTCAT 
Dll 1 F: CTGGGTGTCGACTCCTTCAG 124 NM_007865  
R: GGAGGGCTTCAATGATCAGA 
Dll 4 F: AGGTGCCACTTCGGTTACAC 72 NM_019454  
R: TAGAGTCCCTGGGAGAGCAA 
Jagged 1 F: GGAAGTGGAGGAGGATGACA 95 NM_013822  
R: GGGCCTTCTCCTCTCTGTCT 
Jagged 2 F: TTGTTATGGGTGGCTCTTCC 80 NM_010588  
R: AGCCACAGCACACTGAACAC 
Hes 1 F: ACACCGGACAAACCAAAGAC 148 NM_008235  
R: ATGCCGGGAGCTATCTTTCT 
Hey 1 F: TTTTCCTTCAGCTCCTTCCA 92 NM_010423  
R: ATCTCTGTCCCCCAAGGTCT 
Hey l F: GGTGACTTCCACCCAGAGAG 99 NM_013905  
R: GGGATTGGGACTATGCTCCT  
aF, forward; R, reverse. 
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Table 8. Up-regulated cell cycle-related genes in the vagina of ovariectomized 10-week-old mice exposed 
neonatally to 2.5 g DES  
Gene accession no. Name 
Fold 
change 
Prove set ID 
NM_028390  anillin, actin binding protein 3.9  1433543_at 
NM_027106  arginine vasopressin-induced 1 4.6  1423122_at 
NM_011497  aurora kinase A 3.2  1424511_at 
NM_025415  CDC28 protein kinase regulatory subunit 2 3.2  1417457_at 
NM_025415  CDC28 protein kinase regulatory subunit 2 3.1  1417458_s_at 
NM_007659  cell division cycle 2 homolog A (S. pombe) 3.7  1448314_at 
NM_023223  cell division cycle 20 homolog (S. cerevisiae) 4.2  1416664_at 
NM_023223  cell division cycle associated 20 homolog (S. cerevisiae) 4.5  1439377_x_at
NM_026410  cell division cycle associated 5 3.8  1416802_a_at
NM_001164362  centrosomal protein 55 2.3  1452242_at 
NM_024190  chromatin modifying protein 1B 2.1  1418816_at 
NM_009828  cyclinA2 3.3  1417910_at 
NM_009828  cyclinA2 3.6  1417911_at 
NM_001111099  cyclin-dependent kinase inhibitor 1A (P21) 7.1  1424638_at 
NM_013726  DBF4 homolog (S. cerevisiae)  2.2  1418334_at 
NM_010288  gap junction protein, alpha 1 6.3  1415801_at 
NM_001001999  glycoprotein 1b beta, polypeptide septin 5 4.6  1452357_at 
NM_001130443  Harvey rat sarcoma virus oncogene 1 2.4  1422407_s_at 
NM_001130443  Harvey rat sarcoma virus oncogene 1 2.2  1424132_at 
NM_016692  inner centromere protein  2.3  1439436_x_at
NM_019499  MAD2 mitotic arrest deficient-like 1 (yeast) 2.3  1422460_at 
NM_015806  mitogen-activated protein kinase 6 2.9  1419169_at 
NM_010937  neuroblastoma ras oncogene Nras 2.0  1422688_a_at
NM_152804  polo-like kinase 2 (Drosophila) 2.2  1427005_at 
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NM_145150  protein regular of cytokinesis 1 2.9  1423775_s_at 
NM_012025  Rac GTPase-activating protein 1 2.7  1421546_a_at 
NM_033144  septin 8 2.9  1426801_at 
NM_033144  septin 8 3.2  1426802_at 
NM_018754  stratifin 8.5  1448612_at 
NM_026785  ubiquitin-conjugating enzyme E2c 7.6  1452954_at 
NM_021284  v-ki-ras2 kirsten rat sacrona viral oncogene homolog  2.0  1451979_at 
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Table 9. Down-regulated cell cycle-related genes in the vaina of ovariectomized 10-week-old mice 
exposed neonatally to 2.5 g DES   
Gene accession no. Name 
Fold 
change 
Prove set ID 
NM_007631  cyclinD1 0.3 1448698_at 
NM_007631  cyclinD1 0.4 1417420_at 
NM_001161624  cyclin-dependent kinase inhibitor 1C (P57) 0.4 1417649_at 
NM_008321  inhibitor of DNA binding 3 0.5 1416630_at 
NM_011317  
KH domain containing, RNA binding, signal 
transduction associated 2 
0.5 1438462_x_at
NM_019946  microsomal glutathione S-transferase 1 0.3 1415897_a_at
NM_013871  mitogen-activated protein kinase 12 0.4 1449283_a_at
NM_011250  retinoblastoma-like 2 0.5 1418146_a_at
NM_001009935  thioredoxin interacting protein 0.5 1415996_at 
NM_001009935  thioredoxin interacting protein 0.5 1415997_at 
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V. Chapter 4 
Sequential Changes in Expression of Wnt- and Notch-Related 




The rodent vaginal epithelium exhibits cyclical changes in response to cyclical 
ovarian secretions of sex hormones, displaying an alternating pattern of keratinization 
and mucification (Long and Evans, 1922). The mouse vagina is a good model to study 
epithelial cell proliferation and keratinization. In ovariectomiced mice, estrogens induce 
proliferation of the vaginal epithelial cells together with superficial keratinization. In 
response to estrogens, basal epithelial cells proliferate rapidly, leading to the formation 
of a highly stratified epithelium (Evans et al., 1990; Suzuki et al., 1996; Sato et al., 
2003). Estrogens alter cellular physiology by modulating the transcriptional activity of 
specific nuclear estrogen receptors (ERs) (Cooke et al., 1998), which are believed to 
stimulate primary response genes, initiating a cascade of transcriptional events, the 
products of which participate in physiological responses known to be 
estrogen-dependent events in the target organs in vivo (Mangelsdorf et al., 1995). 
However, the regulation of vaginal gene expression by estrogens and the molecular 
mechanisms underlying estrogen-mediated cell proliferation remain unclear. 
Previously, we reported expression patterns of mRNAs in the persistently 
altered vagina of neonatal mice exposed to diethylstilbestrol (DES) using DNA 
microarray and real-time quantitative reverse transcription-polymerase chain reaction 
(RT-PCR) (Miyagawa et al., 2004a,b; Suzuki et al., 2007b; Nakamura et al., 2008, 
2012a,b). In the vagina exposed neonatally to DES, we found that wingless-related 
MMTV integration site 4 (Wnt4) was up-regulated without estrogen stimulation and 
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was correlated to the keratinization of the vaginal epithelium (Nakamura et al., 2012a). 
Moreover, we identified up-regulation of p21 (also called Waf1, Cap20, Cip1 and Sdi1) 
and down-regulation of hairy and enhancer of split 1 (Hes1), hairy/enhancer-of-split 
related with YRPW motif 1 (Hey1) and Heyl which are target genes of Notch signaling 
pathway (Nakamura et al., 2012b) in the neonatally DES-exposed mouse vagina. These 
genes likely lead to persistent cell proliferation and differentiation in the murine vagina 
due to neonatal DES exposure. 
The estrogen-responsive genes mentioned above in the vagina identified by gene 
profiling provide an important foundation for understanding functional mechanisms of 
estrogen regulating morphogenesis and maintenance of the reproductive organ. 
However, no comprehensive studies have been conducted on mRNA expression of 
these genes in the vagina and uterus in mice after estrogen exposure. In the present 
study, I analyzed sequential changes of these gene expressions in the vagina, in 
comparison to the uterus, of ovariectomized mice given a single injection of 
17 -Estradiol (E2).
2. Materials and Methods 
2.1. Reagents 
E2 and sesame oil were obtained from Sigma Chemical Co. (St. Louis, MO, 
USA) and Kanto Chemical (Tokyo, Japan), respectively. 
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2.2. Animals and treatments  
C57BL/6J mice purchased from CLEA Japan (Tokyo, Japan) were maintained 
under 12 h light/12 h dark at 23-25°C and fed laboratory chow (CE-2; CLEAJapan) and 
tap water ad libitum. All procedures and protocols were approved by the Institutional 
Animal Care and Use Committee at the National Institute for Basic Biology, National 
Institutes of Natural Sciences. 
C57BL female mice ovariectomized at 8 weeks of age were given a single 
abdominal injection of 50 ng E2/g body weight (bw) dissolved in sesame oil at 10 weeks 
of age, and sacrificed at 3, 6, 9, 12, 18, 24, 36 or 48 h after the injection, or just before 
injection (0). Vaginae and uteri of these mice were used for real-time quantitative 
RT-PCR. Three mice were used for each time point. 
In addition, C57BL mice ovariectomized at 8 weeks were given a single 
abdominal injection of 50 ng E2/g bw (n=3) or the oil vehicle alone (n=3) at 10 weeks 
of age. These mice were given a single injection of 50 g of bromodeoxyuridine 
(BrdU)/g bw 22 or 46 h after the E2 injection, and were then sacrificed 2 h after the 
BrdU injection. These mice were used for histology and immunohistochemistry.  
2.3. BrdU immunostaining  
Tissues embedded in paraffin were sectioned at 8 m and stained with hematoxylin 
and eosin. In addition, deparaffinized sections were incubated in 0.3% H2O2 in 
methanol for 30 min, then immersed in 2 N HCl for 20 min in order to denature the 
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genomic DNA. After washing with phosphate-buffered saline (PBS) in 0.5% Tween, 
the sections were incubated with anti-BrdU antibody (Boehringer Mannheim, 
Mannheim, Germany) diluted 1:20 in PBS containing 1% bovine serum albumin (BSA) 
(SigmaChemical, Co.) overnight at 4 . The sections were subsequently incubated with 
3,3-diaminobenzidine tetrahydrochloride containing hydrogen peroxide. BrdU-labeling 
index (percentage) was estimated by counting the number of BrdU-incorporated cells 
per h in the basal layer of vaginal epithelium as described previously (Miyagawa et al., 
2004a,b). 
2.4. Real-time quantitative RT-PCR
Total RNA, isolated with RNeasy kit (Qiagen, Chatsworth, CA, USA) from 
each group of vaginae, was used for real-time quantitative RT-PCR reactions carried out 
with SuperScript III reverse transcriptase (Invitrogen, Carlsbad, CA, USA).
Changes in gene expression were confirmed and quantified using the ABI Prism 
5700 Sequence Detection System (Applied Biosystems, Foster City, CA, USA) and 
instructions. PCR conditions were as follows: 50
l volumes. Relative RNA equivalents 
for each sample were obtained by standardization of L8 ribosomal protein levels. 
Sequences of gene primer sets are given in Table 9. Three pools of samples per group 
were run in triplicate to determine sample reproducibility, and the average relative RNA 
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equivalents per sample were used for further analysis. Error bars represent the standard 
error, with all values represented as fold change compared to the control treatment 
group normalized to an average of 1.0. 
2.5. Immunohistochemistry
Tissues were fixed in 10% neutral buffered formalin, embedded in paraffin and 
sectioned at 4 m. The sections deparaffinized were incubated with 0.3% H2O2 in 
methanol for 15 min to eliminate endogenous peroxidase. After washing with PBS, the 
sections were stained with LSABTM 2 kit, Universal (Dako, Carpinteria, CA, USA) 
according to the manufacturer-supplied protocol. Polyclonal antibody to Wnt4 was 
obtained from R&D Systems, Inc. (Minneapolis, MN, USA). The tissue sections were 
incubated at 1:200 dilution in PBS containing 1% BSA overnight at 4 . For negative 
controls, normal goat immunoglobulin (IgG) fraction (Dako) was used at the same 
dilution. Monoclonal antibody to p21 was obtained from Santa Cruz, Inc. (Minneapolis, 
MN, USA). The sections were incubated at 1:50 dilution in PBS containing 1% BSA 
overnight at 4 . For negative controls, murine IgG2b (Dako) was used at the same 
dilution. 
2.6. Statistical analysis
Statistical analyses were performed using one-way analysis of variance 
(ANOVA). Differences or p<0.05 were considered significant.
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3. Results 
3.1. Morphological changes and differential expression of cell cycle-related genes in 
vaginae of ovariectomized mice given a single injection of E2
Histological changes in the vagina following the E2 injection are shown in Fig. 
12A-C. The epithelium exhibited proliferation at 24 h (Fig. 12B), and underwent 
stratification with superficial keratinization at 48 h after the injection (Fig. 12C). The 
basal cells of vaginal epithelium at 24 h after the injection exhibited a high proliferative 
activity (10.2%), confirmed by BrdU immunostaining (Fig. 12D). At 48 h after the 
injection, proliferative activity declined to 4.0% (Fig. 12D).  
Since cyclin A2 is expressed from S phase to M phase during cell division, 
sequential changes in gene expression levels of cyclin A2 in addition to keratin 1 were 
examined after E2 treatment. The gene expression of cyclin A2 was increased 18-24 h 
after E2 treatment (Fig. 13A), and that of keratin 1 had a similar pattern to that of cyclin 
A2 (Fig. 13B). Up-regulation of cyclin A2 and keratin 1 was correlated with epithelial 
stratification and keratinization in the vagina. 
3.2. Localization of Wnt4 and p21 proteins in mouse vagina 
The localization of Wnt4 and p21 protein in the proliferating epithelial cells of 
vaginae was examined by immunohistochemistry (IHC). Wnt4 staining was observed in 
the basal and middle layers of vaginal epithelium at 24 h after the E2 injection (Fig. 
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14A). p21 was localized in the basal layer of vaginal epithelium in E2-treated mice (Fig. 
3C). No response was visible in the vaginal epithelium stained with normal goat 
immunoglobulin (IgG) as a negative control (Fig. 14B and D). Hence, Wnt4 and p21 
proteins were evident in the proliferating vaginal epithelial cells. 
3.3. Differential expression of Wnt genes and Notch signal pathway-related genes in 
the vagina and uterus of ovariectomized mice given a single injection of E2
On the basis of the morphological findings in the vagina of ovariectomized mice 
given E2, I compared the expression patterns of Wnt genes and Notch signal 
pathway-related genes in the vagina and uterus after treatment with E2. In the vagina, 
expression of Wnt4 was increased at 18 and 24 h after the E2 injection, while in the 
uterus, the expression was transiently increased only at 3 h (Fig. 15A). Expression of 
Wnt5a was increased at 12 and 24 h after E2 injection in the vagina and at 18, 24 and 36 
h in the uterus, respectively (Fig. 15B). Expression of Wnt11 was decreased at 6-36 h 
after E2 administration in the vagina and at 9-24 h in the uterus, respectively (Fig. 15C). 
The expression of Wnt4 was different between the vagina and uterus, while the pattern 
for Wnt5a and Wnt11 revealed a similar trend in both organs. 
Expression of Hey1 was decreased at 3-24 h after the E2 injection in the vagina. 
On the other hand, the expression increased transiently at 3 h in the uterus (Fig. 15D). 
Expression of Hey2 was decreased at 12, 24 and 36 h in the uterus, while in the vagina, 
the expression was decreased at 6, 36 and 48 h (Fig. 15E). Expression of Heyl was 
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increased at 6-12 h after the administration only in the uterus (Fig. 15E and F). However, 
the expression showed no change in the vagina after the E2 injection (Fig. 15F). 
Expression of Dll1 was increased in the uterus at 6 h after administration, while the 
expression remained unchanged in the vagina (Fig. 15G). Expression of Dll4 was 
decreased in the vagina at 3, 9, 18-48 h after E2 administration and in the uterus at 3-24 
h (Fig. 15H). 
The expression of p21 and p53 was increased at 6-12 h after E2 administration in 
the uterus (Fig. 15I and J). In vagina, however, E2 injection only increased p21
expression at 12 h, with no effect on the expression of p53 (Fig. 15I and J). 
4. Discussion 
Estrogens induce epithelial cell proliferation and differentiation, whereas 
estrogen depletion results in atrophy accompanied by apoptosis in adult female mouse 
reproductive organs, such as the vagina and uterus (Evans et al., 1990; Suzuki et al., 
1996; Sato et al., 2003). In order to understand the underlying mechanisms of estrogen 
functions in reproductive organs in mice, Kitajewski et al. (2000) and Suzuki et al. 
(2007a,b) have analyzed estrogen-responsive genes in reproductive organs, and found 
that expression patterns of genes are different between the vagina and uterus. Previously, 
we reported the expression of Wnt- and Notch-related genes in the vagina and uterus 
exposed neonatally to DES (Suzuki et al., 2007b; Nakamura et al., 2008; Nakamura et 
al., 2012a,b), and the localization of Wnt4 or p21 proteins and quantitation of 
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BrdU-positive cells after E2 administration in the ovariectomized mouse uterus (Lai et 
al., 2002; Hou et al., 2004). In the vagina, however, detailed information has not been 
reported. Therefore, I investigated gene expression of Wnt- and Notch-related genes in 
the vagina and uterus after a single injection of E2 in mice. 
; Kitajewski and Sossoon, 2000; Mericskay 
et al., 2004) reported that Wnt4, Wnt7a, and Wnt5a are required for Müllerian duct 
formation, subsequent differentiation, and posterior growth, respectively, and the 
expression of these genes in the uterus changes during the estrous cycle (Miller et al., 
1998). These findings suggest important roles of Wnt family genes in various 
reproductive physiologies. In the present study, Wnt4, but not Wnt5a and Wnt11, were 
differently expressed pattern in the vagina and uterus.  
Cyclin A2 is expressed from S phase to M phase, so the cell cycle phase after E2
treatment can be determined by analyzing changes in cyclin expression (Katsu and 
Iguchi, 2006). In the present study, expression of cyclin A2 and keratin 1 was increased 
24 h after a single injection of E2 in the vagina, being similar to the BrdU labeling index 
and expression of Wnt4. These results suggest that Wnt4 might act on epithelial 
stratification and keratinization in the vagina. In the uterus, Wnt4 was transiently 
increased at 3 h after E2 treatment; Wnt4 is expressed in the uterine epithelium at 
proestrus at the time of highest estrogen levels (Miller et al., 1998; Rugh, 1990), 
suggesting that estrogen regulates Wnt4 expression in the uterus. On the other hand, 
Wnt5a and Wnt11 had similar expression patterns in the vagina and uterus. Wnt5a
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expression has been reported to change in both organs during the estrous cycle (Miller 
et al., 1998), and it is expressed at higher levels at proestrus in the vaginal epithelium 
and stroma (Miller et al., 1998), suggesting involvement in cell proliferation and 
keratinization in the vagina. I confirmed the similarity of the expression patterns among 
Wnt5a, cyclin A2 and keratin 1 in the vagina in the present study. In the uterus, Wnt5a
has been detected in both the epithelium and the stroma at estrus, but only uterine 
stroma at proestrous (Miller et al., 1998). Zhu et al. (2004) reported that the expression 
of Wnt11 is inhibited by androgen. The present data indicate that Wnt11 is 
down-regulated in both organs by E2 treatment, showing negative correlation with cell 
proliferation in both organs, as in the vagina of neonatally DES-exposed mice 
(Nakamura et al., 2012a). 
Previously, we reported that Hey1 and Heyl, Notch target genes, are persistently 
down-regulated in the vagina exhibiting estrogen-independent epithelial cell 
proliferation in the neonatally DES-exposed mice (Nakamura et al., 2012a). In this 
study, Hey1, Hey2 and Heyl had differential expression patterns between vagina and 
uterus in response to E2 stimulation. Hey1 was down-regulated at 3-24 h after E2
treatment in the vagina, suggesting the opposite behavior in proliferation of vaginal 
cells to that of uterine cells. Hey1 and Heyl may have roles in maintaining 
undifferentiated quiescent cells, as in satellite muscle cells (Fukada et al., 2011).  
We reported that Notch ligand genes, Dll1 and Dll4, are unaltered in the vagina 
exhibiting estrogen-independent epithelial cell proliferation in the neonatally 
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DES-exposed mice (Nakamura et al., 2012b). Dll1 and Dll4 genes had a differential 
expression pattern between the vagina and uterus after E2 treatment in this study. 
Expression of Dll1 was transiently increased 6 h after E2 stimulation but it showed no 
change in the vagina. Dll4 is reported to be involved in tumor angiogenesis 
(Noguera-Troise et al., 2006; Ridgway et al., 2006), and is expressed in the arterial 
endothelium (Shutter et al., 2000). Dll4, as well as Wnt11, exhibited down-regulation by 
E2 in both organs, suggesting a negative correlation with cell proliferation. 
Finally, I confirmed the expression of p21 and p53. p21 is a direct target of p53 
tumor suppressor, and mediates p53-dependent cell cycle arrest in response to DNA 
damage (el-Deiry et al., 1993). In this study, I found the expression patterns of p21 and 
p53 in the uterus were similar. 
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Fig. 12. Histology of vagina of a 10-week-old, mouse ovariectomized at 8 weeks of age, 
and killed just before (A) or 24 h (B) and 48 h (C) after a single abdominal injection of 
50 ng 17 -Estradiol (E2)/g bw dissolved in sesame oil at 10 weeks of the injection. 
Bar=50 m. Incidence (%) of BrdU-incorporated basal cells in the vaginal epithelium of 
mice sacrificed before injection, and 24 and 48 h after a single E2 injection (D). Data are 
the means standard error (n=3). ***p<0.001 vs. controls (one-way ANOVA). 
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Fig. 13. Fold expression of cyclin A2 (A) and keratin 1 (B) after a single injection of 50 
ng 17 -Estradiol (E2)/g bw. Expression of these genes in control mice was regarded as 
the basal level (1.0). Data are the means standard error (n=3). *p<0.05 and 
***p<0.001 vs. controls (one-way ANOVA). 
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Fig. 14. Immunohistochemistry by wingless-related MMTV integration site 4 (Wnt4) 
(A) and p21 (C). Vaginae of 10-week-old, ovariectomized mice were killed at 24 h after 
a single injection of 17 -Estradiol (E2). For negative controls, sections were incubated 
with preimmune serum instead of primary antibody (B, D). Bar=50 m. The boundary 
between the epithelium and stroma is indicated by a dotted line. 
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Fig. 15. Fold expression of wingless-related MMTV integration site 4 (Wnt4) (A), 
Wnt5a (B), Wnt 11 (C), hairy/enhancer-of-split related with YRPW motif 1 (Hey1) (D), 
Hey2 (E), Heyl (F), delta-like 1 (Dll1) (G), Dll4 (H), p21 (I) and p53 (J) in the vagina 
and uterus after a single injection of 50 ng 17 -Estradiol (E2)/g bw. Expression of these 
genes in control mice before E2 injection (0 h) was regarded as the basal level (1.0). 
Data are the means standard error (n=3). *p<0.05, **P<0.01 and ***P<0.001 vs. 
controls (one-way ANOVA). 
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Table 10. Sequences of gene primer sets for real-time quantitative RT-PCR   
Gene - a Product size (bp) Gene accession no. 
Cyclin A2 F: ACAGAGCTGGCCTGAGTCAT 119 NM_009828 
R: TTGACTGTTGGGCCATGTTGT  
Keratin 1 F: AAGAGGACCAACGCAGAGAA 87 NM_008473 
R: TTGGCCTGAAGCTCAACTTT  
Wnt4 F: CATCGAGGAGTGCCAATACCA 70 NM_009523 
R: GACAGGGAGGGAGTCCAGTGT   
Wnt 5a F: GCGTGGCTATGACCAGTTTAAGA 75 NM_009524 
R: TTGACATAGCAGCACCAGTGAA    
Wnt11 F: ATGTGCGGACAACCTCAGCTA 100 NM_009519 
R: CGCATCAGTTTATTGGCTTGG   
Dll 1 F: CTGGGTGTCGACTCCTTCAG 124 NM_007865 
R: GGAGGGCTTCAATGATCAGA   
Dll 4 F: AGGTGCCACTTCGGTTACAC 72 NM_019454 
R: TAGAGTCCCTGGGAGAGCAA   
Hey 1 F: TTTTCCTTCAGCTCCTTCCA 92 NM_010423 
R: ATCTCTGTCCCCCAAGGTCT   
Hey 2 F: CAGTCCTCAGCAGACAAGAC 73 NM_013904 
R: GGTTGGGCATGTAAGTGTAGTTGT   
Hey l F: GGTGACTTCCACCCAGAGAG 99 NM_013905 
R: GGGATTGGGACTATGCTCCT   
p21 F: GTACTTCCTCTGCCCTGCTG 70 NM_001111099 
R: AGAGTGCAAGACAGCGACAA   
p53 F: AAAGGATGCCCATGCTACAG 92 NM_011640 
R: TATGGCGGGAAGTAGACTGG 
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VI. Summary and Conclusion 
Proliferation and differentiation of cells in the female reproductive organs, 
oviduct, uterus and vagina, are regulated by endogenous estrogens. In utero exposure to 
a synthetic estrogen, diethylstilbestrol (DES), induces vaginal clear-cell 
adenocarcinoma in humans (Herbst et al., 1971; Herbst and Bern, 1981). In mice, 
perinatal exposure to DES and estrogenic chemicals, results in abnormalities such as in 
the hypothalamo-pituitary-gonadal axis, polyovular follicles, uterine circular muscle 
disorganization and persistent vaginal epithelial cell proliferation. Activities of 
estrogenic chemicals are mediated through estrogen receptors  (ER ) and/or ER . 
However, little is known about the relative contribution of the individual ER subtypes in 
the induction of abnormalities.  
I therefore tested the effects of neonatal exposure to ER selective ligands and 
DES on the female mouse vagina and uterus. Transactivation assays using mouse ER
and ER  showed that 10-10 M DES activated both ER subtypes and that the ER  agonist 
(propyl pyrazole triol, PPT) and the ER  agonist (diarylpropionitrile, DPN) selectively 
activated their respective ER subtypes at 10-9 M. Female mice injected neonatally with 
DES, PPT or DPN were examined at 13 and 15 weeks of age. Persistent estrus and 
anovulation were induced in all mice by 0.025-2.5 g DES and 2.5-25 g PPT, but not 
by DPN, suggesting that the observed anovulation was primarily mediated through ER . 
Disorganization of uterine musculature and ovary-independent vaginal epithelial cell 
proliferation accompanied by persistent expression of EGF-related genes and 
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interleukin-1-related genes were also mediated through ER . In contrast, polyovular 
follicles were induced by neonatal treatment with both ER  and ER  ligands, 
suggesting that ovarian abnormalities are mediated through both ER subtypes (Chapter 
1).  
I examined global gene expressions in the vagina of ovariectomized adult mice 
exposed neonatally to DES using microarray to understand the underlying mechanism 
of the estrogen-independent persistent vaginal changes induced by neonatal DES 
exposure. I found persistent up-regulation of Wnt4 and persistent down-regulation of 
Wnt11 in the vaginae of mice exposed neonatally to DES and PPT. Also, the expression 
of Wn4 protein in vagina is correlated to the stratification of epithelial cells with the 
superficial keratinization of vaginae, but not epithelial cell stratification alone (Chapter 
2). 
Moreover, the expression of cell cycle-related genes, p21, cyclin-dependent 
kinase inhibitor, showed up-regulation in the vagina, and p21 protein was localized in 
the basal layer of the vaginal epithelium in mice exposed neonatally to DES and PPT. 
The expression of Notch receptors and Notch ligands were unchanged, however, 
hairy-related  (bHLH) transcription factor genes, Hes1, Hey1 and 
Heyl were persistently down-regulated in the vaginae showing estrogen-independent 
epithelial cell proliferation in mice exposed neonatally to DES and PPT (Chapter 3). 
Female reproductive organs show organ-specific morphological changes during 
estrous cycles. Estrogen depletion by ovariectomy in adults results in atrophy 
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accompanied by apoptosis in vaginal and uterine cells, while estrogen treatment 
following the ovariectomy elicits cell proliferation in both organs. Sequential changes in 
mRNA expression of Wnt and Notch signalling genes were analysed in the vaginae and 
uteri of ovariectomized adult mice after a single injection of 17 -estradiol (E2) to 
understand molecular basis of differences in response to estrogen in these organs. I 
found estrogen-dependent up-regulation of Wnt4, Wnt5a and p21 and down-regulation 
of Wnt11, Hey1 and Dll4 in the vaginae, and up-regulation of Wnt4, Wnt5a, Hey1, Heyl, 
Dll1, p21 and p53 and down-regulation of Wnt11, Hey2 and Dll4 in the uteri. The 
expression of Wnt4, Hey1, Hey2, Heyl, Dll1 and p53 showed different expression 
patterns after estrogen injection. Whereas, Wnt5a, Wnt11, Dll4 and p21 showed similar 
expression patterns between the vaginae and uteri, suggesting that these genes are 
involved in proliferation of cells in both organs in mice (Chapter 4). 
In conclusion, neonatal treatment with both ER  and ER  selective agonists, 
induced polyovular follicles. Therefore, both ER subtypes are involved in induction of 
ovarian abnormalities. In contrast, anovulatory sterility, disorganization of uterine 
circular muscle and persistent proliferation of vaginae were induced by neonatal 
treatment with DES or an ER -selective ligand, PPT, but not an ER -selective ligand, 
DPN. I conclude that ER  action is essential for induction of abnormalities in the 
hypothalamo-pituitary-ovarian axis, and uterine and vaginal changes during the critical 
developmental period in mice. Furthermore, in the vaginae exposed neonatally to DES 
or PPT, I found that permanent up-regulation of Wnt4 mRNA, and permanent 
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down-regulation of Wnt11 mRNA, suggesting that Wnt4 participates in the irreversible 
superficial keratinization in the mouse vagina, however, Wnt11 participates in an 
ER-independent repressive role in vaginal keratinization. In addition, I demonstrated 
that expression of both p21 mRNA and p21 protein are permanently up-regulated, and 
Hes1, Hey1 and Heyl mRNAs are permanently down-regulated in the vaginae exposed 
neonatally to DES. I examined the global expression of mRNA, focusing on growth 
factors in the vagina of mice exposed neonatally to DES, showing persistent hyperplasia 
and the superficial keratinization. I also performed comprehensive analyses on the 
expression of Wnt- and Notch-related genes in the vaginae exposed neonatally to DES. 
Wnt family genes or Notch family genes are one of the fundamental signalling 
pathways that regulate metazoan development and adult tissue homeostasis. I confirmed 
persistent up-regulation of Wnt4 and p21, and persistent down-regulation of Wnt11, 
Hes1, Hey1 and Heyl, and localization of Wnt4 and p21 protein in the vaginae exposed 
neonatally to DES. I also demonstrated the difference in expression patterns of Wnt4, 
Wnt5a, Wnt11, Hey1, Hey2, Heyl, Dll1, Dll4, p21 and p53 between the vaginae and 
uteri after E2 stimulation. Moreover, I identified the localization of Wnt4 and p21 
protein in the ovariectomized adult mouse vagina exhibiting epithelial stratification 
after a single injection of E2. Especially, Wnt4, Wnt11, p21 and Hey1 showed similar 
trends in the vagina exposed neonatally to DES. These data might provide clues to the 
biological function of genes involved in the irreversible proliferation in vaginal 
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epithelial cells. Additional elucidation of the molecular mechanism of cell proliferation 
in the vagina and uterus is essential in the near future.  
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